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ABSTRACT 
Toll-like receptors (TLRs) recognize microbial components as danger signals and 
induce immune responses. TLR’s are expressed in many tissues of the host that are involved 
in immune responses including the intestines where they are abundantly expressed. This 
situation presents a challenge in the gastrointestinal tract which is constantly exposed to a 
wide variety of commensal organisms. Therefore, innate immune recognition in the intestine 
must be tightly regulated to prevent unwanted inflammation against harmless commensal 
micro-organisms and yet allow for the induction of protective immunity to invading 
pathogens. A dysregulation of this balance can result in intestinal inflammation. 
 
 Peyer’s patches (PP) are the primary site for the induction of immune responses in 
the intestine and abundantly express TLRs. It is not known how PP regulate microbial signals 
from commensal bacteria and yet mount vigorous immune responses against dangerous 
pathogens. CpG DNA, an agonist for TLR9, can strongly activate immune cells in blood, 
lymph nodes and spleen. However, CpG very poorly activates immune cells from Peyer’s 
patches, although these cells express TLR9 [1, 2]. Understanding how TLR responses are 
regulated in PP cells will unveil important information on how immune responses are 
regulated in the intestine. 
 
Investigations from our laboratory have revealed a B cell population (CD5-CD11c-
CD21+) in PP that spontaneously secrete high levels of IL-10 which in turn down regulates 
TLR9 induced IFN and IL-12 production. These IL-10-secreting PP B cells represent a 
novel subset of the recently proposed regulatory B cells (Bregs) in the intestine [1, 3]. Bregs 
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may have a role in maintaining tolerance to commensal bacteria thereby achieving intestinal 
homeostasis. 
 
The overall goal of the work described in this thesis was to improve our 
understanding of the immunobiology of Bregs. We performed several experiments to achieve 
this goal. First, we studied the development of regulatory B cells in lambs of different ages. 
Jejunal PP were collected from 3-4 month old, neonatal and fetal lambs and the production 
of IL-10 (the immunoregulatory cytokine secreted by Bregs) was assayed. We found that IL-
10 was secreted by CD21+ B cells from the PP in all the three age groups, confirming that 
Bregs develop prior to birth. We then wondered whether our CD21+ B cells might be 
contaminated with other cells or activated when using MACS to enrich B cells. To address 
this issue, we prepared very highly purified CD21+ B cell population using high speed cell 
sorting to negatively enrich for B cells. We also sorted DCs and assayed IL-10 production 
in both cell populations. Only the PP B cells spontaneously secreted IL-10. In contrast, 
dendritic cells, T cells, macrophages, neutrophils and NK cells did not secrete detectable 
IL-10.  
 
Since B cells exist as regulatory and effector populations in mice, we wondered 
whether an effector B cell population also existed in ovine PP that secreted the pro-
inflammatory cytokines IFN-α, IFN-γ and IL-12. Therefore, ovine PP B cells were 
fractionated into CD72+CD21+and CD72+CD21- subpopulations to assess their capacity to 
secrete pro-inflammatory cytokines. Interestingly, the CD72+CD21- B cell population 
secreted the cytokines IFN-α, IFN-γ and IL-12 suggesting there was an effector population. 
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We then surveyed for Bregs in different mucosal and peripheral tissues in sheep. We observed 
the Bregs frequency varied among the different lymphoid tissues. Finally, we investigated 
whether Bregs were present in PP of other ruminant species. We identified Bregs exist in PP 
of neonatal calves. 
 
In conclusion, our investigations reveal that ovine Bregs develop in utero prior to 
antigen exposure, and are present in a variety of mucosal and peripheral tissues. We also 
report the novel observation that two distinct B cell sub-populations are present in ovine 
jejunal PP’s: Regulatory and effector B cells. 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Overview of innate immunity 
1.1.1      Definition 
The innate immune system is the body’s first line of defence against infection including 
both soluble factors and cells. Cells of the innate immune system express genetically encoded 
receptors called pattern recognition receptors (PRR), which can detect pathogen-associated 
molecular patterns (PAMPs) as danger signals [4]. The innate immune system includes a wide 
variety of immune cells, including dendritic cells (DCs), macrophages, neutrophils and natural 
killer (NK) cells. 
 
 1.1.2     Pathogen Associated Molecule Patterns (PAMPs) 
PAMPs are distinct molecular motifs present on microbial organisms and not in the host. 
They are recognized by evolutionarily conserved germ-line encoded receptors known as 
pattern recognition receptors (PRR) which are expressed in host cells [4, 5]. Most PRR detect 
pathogens regardless of their life cycle with exceptions of ds RNA that are only present during 
viral replication. PRR and are present intracellularly or extracellularly on the cell surface. 
Different classes of PRR, such as Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), 
NOD-like receptors (NLRs), scavenger receptors, lectin receptors and DNA receptors 
(cytosolic sensors for DNA), have been described [4, 6]. These PRR are at the forefront of 
both extracellular and intracellular pathogen recognition and sense various classes of microbial 
molecules including proteins, lipids, carbohydrates and nucleic acids [7-10]. 
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1.1.3     Toll Like Receptors (TLR) 
TLR are a family of transmembrane receptors homologous to Drosophila toll proteins 
[6, 9, 11]. They are the most widely studied PRRs and are considered to be the primary sensors 
of pathogens. TLRs are type I trans-membrane glycoproteins and are made up of extracellular 
leucine rich repeats (LRRs) and a cytoplasmic Toll/ interleukin-1 receptor (TIR) domain. The 
LRRs are required for PAMP recognition, and the cytoplasmic Toll/ interleukin-1 receptor 
(TIR) domain is required for downstream signalling. To date, 13 members of the TLR family 
have been identified in mammals (10 in humans and 12 in mice), with each receptor 
recognizing a unique set of PAMP (Table 1)[12]. TLR1, 2, 4, 5, 6 and 10 are primarily 
expressed on the cell surface and recognize PAMPs derived from bacteria, fungi and protozoa, 
whereas TLR3, 7, 8 and 9 are exclusively expressed within endocytic compartments and 
primarily recognize nucleic acid PAMPs derived from various viruses and bacteria [6, 13]. 
Restricted access to these TLRs may be important to prevent aberrant activation by self-
nucleic acids released from apoptotic/ necrotic cells, which could lead to autoimmune diseases. 
 
Most TLRs signal via an adaptor protein called myeloid differentiation factor 88 
(MyD88), except for TLR3, which signals through TIR domain-containing adaptor- inducing 
interferon-b (TRIF), and TLR4, which signals through both. Both MyD88 and TRIF pathways 
elicit transcriptional alterations through the activation of nuclear factor-k B (NFKβ) and other 
transcription factors [6].   
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Table 1. TLRs and their respective ligands 
TLR Agonist Cells expressing TLR Reference 
TLR1 
 
TLR2 
 
 
 
TLR3 
 
TLR4 
 
 
 
TLR5 
TLR6 
 
 
TLR7 
 
 
TLR8 
Triacyl lipopeptides  
 
LTA, Zymosan, 
PamCSK4, 
MALP2, 
Lipoarabinomann 
dsRNA, poly(I:C) 
 
LPS, mannan, 
GIPLs, envelope 
proteins, Heat 
shock proteins 
Flagellin 
Diacyl lipopetides, 
LTA, Zymosan 
 
ssRNA, 
Imiquimod,Resiqui
mod 
(R848), synthetic 
polyU RNA, 
Mφ, cDC, neutrophils, B cells, mast cells, 
epithelial cells 
Mφ, cDC, neutrophils, mast cells, 
epithelial cells 
 
 
cDC, Mφ, endo/epithelial cells 
 
cDC, neutrophils, mast cells, eosinophils, 
epithelial cells 
 
 
Monocytes, cDC, IEC, epithelial cells 
Monocytes, mast cells, cDC, neutrophils, 
neutrophils, eosinophils, pDC, epithelial 
cells 
Monocytes, cDC, mast cells, neutrophils, 
epithelial cells  
 
pDC, B cells, NK cells, eosinophils, 
neutrophils, epithelial cells 
[14] 
 
[15] 
 
 
 
[16] 
 
[17] 
 
 
 
[18] 
[19] 
 
 
[20] 
 
 
[21] 
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TLR9 
TLR10 
TLR 11 
TRL 12 
TLR 13 
siRNAs 
Resiquimod 
(R848), ssRNA 
CpG DNA, 
hemozoin 
Not known 
Profilin 
bacterial ribosomal 
RNA sequence 
“CGGAAAGACC” 
 
 
 
pDC, B cells, NK cells, eosinophils, 
neutrophils 
pDC, B cells, DC 
Neurons, pDC, cDC, Mφ 
monocytes/ Mφ 
 
 
 
[22] 
[23] 
[24] 
[25, 26] 
[27, 28] 
 
Mφ – Macrophages, cDC - conventional DC, pDC - plasmacytoid dendritic cells, IEC - 
intestinal epithelial cells, NK - Natural Killer cells, MALP2 - Macrophage Activating 
LipoPeptide-2, GILPS - glycoinositolphospholipids, LPS - Lipopolysaccharides, PolyU RNA 
- polyadenylation uridine ribonucleic acid, LTA – Lipoteichic acid, dsRNA - Double-stranded 
RNA, PamCSK4 - N-palmit-oyl-S-[2-hydroxy-3-(palmitoyloxy)propyl]-(R)-cysteinyl-
(lysyl)3-lysine and Poly(IC) - Polyinosinic:polycytidylic acid. 
 
1.1.4         TLR9 and CpG  
TLR9 recognizes unmethylated CpG motifs of bacterial DNA, as well as synthetic CpG 
oligodeoxynucleotides (ODNs) [29, 30]. TLR9 is also a sensor of DNA of viruses including 
HSV-1, HSV-2 and murine cytomegalovirus, and also recognizes the pigment hemozoin from 
Plasmodium falciparum [31-34]. CpG dinucleotides occur in the expected frequency (1 of 16) 
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in bacterial DNA, but have a suppressed frequency (1 of 64) in vertebrate DNA [35].  It is 
thought that the mammalian immune system has evolved to recognize CpG dinucleotides in 
microbial DNA as a danger signal. Several studies have shown that CpG oligodeoxynucleotides 
(ODN) are potent activators of the innate immune system in numerous species including 
humans, non-human primates, sheep, cattle, pigs, chickens, mice, horses, dogs, cats and fish 
[35-43]. CpG ODN has been shown to induce protective innate immune responses against a 
variety of pathogens including bacteria, viruses and protozoa in numerous animal models [44-
48].  
 
CpG activates a variety of cells including, B-lymphocytes, monocytes, macrophages, 
dendritic cells, NK cells and even mast cells. Activation of these cells with CpG ODN results 
in up-regulation of MHC class I and II, B7-1 and B7-2 co-stimulatory molecules, cell 
proliferation and also induces expression of a broad range of cytokines including IL-1, IL-6, 
IL10, IL-12, IFN-γ and TNF-α [49-52]. In humans, NK cells, eosinophils, neutrophils, 
plasmacytoid dendritic cells (pDCs) and B cells express TLR-9 [53]. Plasmacytoid dendritic 
cells (pDCs) and B cells are directly stimulated by CpG ODN to proliferate, produce cytokines 
and upregulate co-stimulatory molecules [22, 54, 55]. 
 
In-vitro and in-vivo studies have shown that in humans TLR-9 is expressed primarily 
by plasmacytoid dendritic cells (PDCs) and B cells [51]. These cells produce Th1 like pro-
inflammatory cytokines, interferons, and chemokines. Krieg and colleagues have shown that 
certain CpG motifs (CpG-A) are especially potent at activating NK cells and inducing IFN-α 
production by PDCs, while other motifs (CpG-B) are especially potent B cell activators [51]. 
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TLR signalling may play a role in the process of negative selection of B cells [56]. Meffre and 
colleagues found an increased ratio of auto-reactive B cells to naive B cells in patients deficient 
in MyD88 or IRAK4 (a kinase downstream of MyD88 signalling) compared to healthy 
controls, suggesting a defect in negative selection [57]. 
 
1.2      Mucosal Immunity 
The mucosal immune system is at the interface between the internal and external 
environments and interacts with air, water, microbes and food antigens. It is made up of 
inductive and effector sites. Inductive sites are anatomically defined lymphoid compartments 
including Peyer's patches, the mesenteric lymph nodes, appendix and solitary follicles in the 
intestine, the tonsils and adenoids [29]. These inductive sites are where immune responses are 
initiated.  Immune effector sites are the battlegrounds where neutralization of antigen and 
protection of the host against invading pathogens takes place. Effector sites are present in all 
mucosal tissues as disseminated lymphoid tissue diffusely distributed throughout the lamina 
propria [29].  
 
The mucosal tissues constitute efficient barriers, preventing pathogens from gaining 
access to the host but they are also a major route of invasion by pathogenic microorganisms 
[58]. The mucosal immune system has three main functions;  (i) to protect the mucosae against 
colonization and invasion by potentially pathogenic microbes, (ii) to prevent uptake of un-
degraded antigens including foreign proteins derived from ingested food and commensal 
microorganisms, and (iii) to prevent the development of potentially harmful immune responses 
to harmless antigens [59].  
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1.2.1 Gut associated lymphoid tissues 
In the intestine, a balance between immune responses to harmful (or dangerous) 
pathogens and tolerance to harmless antigens from commensals and food must be maintained 
to ensure homeostasis. When this balance is not met or is compromised, the outcome is disease 
conditions such as inflammatory bowel disease, food allergies and malignancies associated 
with inflammation [60].  
 
The gut-associated lymphoid tissue (GALT) consists of both isolated and aggregated 
lymphoid follicles and is one of the largest lymphoid tissues, which is thought to contain up to 
70% of the body’s total lymphocyte population [61]. It is made up of mesenteric lymph nodes 
(MLN) and PP, and more diffusely scattered lymphocytes in the intestinal lamina propria (LP) 
and epithelium [62].  
 
1.2.2        Peyer’s patches 
Peyer’s patches (PP’s) were first described in 1673 by Johann Conrad Peyer after whom 
they are named [63]. They are a group of sub-epithelial lymphoid follicles that are located 
throughout the small intestines [64].  Morphologically, PPs can be divided into three main 
sections: the follicular area, the inter-follicular area and the follicle-associated epithelium [65] 
The PP follicular areas in mice are made up of lymphoid follicles with a germinal center (GC) 
containing proliferating B-lymphocytes, follicular dendritic cells (FDCs) and macrophages. 
The follicle is surrounded by the corona, or sub-epithelial dome (SED) containing mixed-cells 
including B-cells, T-cells, macrophages and dendritic cells (DCs). In sheep, the follicle is 
surrounded by a capsule and lymphatic sinus [66]. 
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The follicle-associated epithelium (FAE) separates the PP from the intestinal lumen. 
The FAE facilitates the movement and transport of bacteria and antigens from the lumen to 
the immune cells underneath it [67]. The FAE also acts as a barrier that prevents interactions 
between the antigens and the immune cells underneath the epithelial surface, therefore 
ensuring a state of tolerance. The Peyer's patches serves as an antigenic sampling site [67]. This 
process involves the complex interplay of a variety of mechanisms that aim to recognize luminal 
antigens, induce an immunological response and decrease the incidence of antigen translocation 
across the mucosal epithelium [67]. The majority of the PP are found in the jejunum and a single 
PP in the ileum [68]. 
 
1.2.2.1       Peyer’s patches in ruminants  
In ruminants, and some other species, there is evidence of two types of Peyer's patches 
(PPs) within the small intestine, the continuous or ileal PP, which extends 150 cm along the 
distal intestine, and the discrete or jejunal PPs distributed throughout the rest of the small 
intestine. These two types of PP differ significantly in their histology, ontogeny and the extent 
of lymphocyte traffic [69, 70]. Another intriguing difference is that the continuous PP involutes 
about the time of puberty whereas  jejunal PPs persist throughout life [70].  
 
1.2.2.2        Ileal Peyer’s patches 
In sheep and cattle, the ileal Peyer’s patch (PP), is a primary lymphoid organ for B-cell 
development [71]. B-cell diversity in the ileal PP is thought to develop by combinatorial 
mechanisms, gene conversion and/or point mutation. During fetal development, Peyer’s 
patches develop first in the jejunum and then the ileum. This happens independent of external 
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antigens [71]. In fetal lambs, lymphopoiesis in ileal and jejunal PP is not dependent on 
exogenous antigens [71]. B cells are generated in the ileal PP at a rate of 3.6 x 109 cells per 
hour in fetal ileal PP [72, 73]. However, very few of the B-cells (up to 5%) produced in the 
ileal PP differentiate and emigrate. Instead the vast majority of the B cells die by apoptosis 
[73]. During fetal development, the ileal PP is not detected until Day 110 of gestation [72].  
Before birth, ileal PP have had no prior contact with exogenous antigen yet B cells proliferate 
at normal rates and this continues for the first two weeks after birth. From about 12 weeks after 
birth the IPP begins to involute and only a few PP follicles remain in this region of the intestine 
by 18 months of age [69, 74]. The ileal PP is made up of about 100,000 closely packed 
elongated follicles with small domes and little inter-follicular area [74]. 
 
1.2.2.3         Jejunal Peyer’s patches  
The JPP are the primary immune inductive sites in the intestine [69]. In sheep and cattle, 
discrete PPs are present as 30-40 lymphoid aggregates in the jejunum [74]. During fetal 
development, ovine JPP develop by Day 65 of the 145-day period of gestation. Each JPP 
contains approximately 100 pear-shaped follicles with very large domes that are well exposed 
to the gut lumen and adjacent lymphoid follicles are separated by abundant inter-follicular 
tissue [74]. Extensive lymphocyte trafficking occurs within the jejunal PP. Lymphocyte 
extravasation is substantially greater in jejunal PPs than in the ileal PP [73]. B cells account 
for the majority of cells (up to 70%) in the JPP whereas T cells account for about 10-30% of 
the cells ([75], [68, 76]). The JPP’s have functional lymphopoietic capacity in utero, and reach 
their maximum size by 2-3 months after birth. The jejunal PP’s, as opposed to the IPP that 
involutes at puberty, remains intact throughout life [70]. What is not known is if the jejunal 
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PP’s function as a primary lymphoid organ in utero but then evolve after birth into a secondary 
organ.  
 
1.2.2.4         Mechanisms of immune regulation in the intestine 
The intestine represents one of the most challenging sites for the immune system as 
immune cells must be able to mount an efficient response to invading pathogens while tolerating 
the large number and diverse array of resident commensal bacteria and food antigens. Excessive 
immune responses lead to uncontrolled inflammation and disease [60]. Intestinal homeostasis is 
achieved, in part, by the integration of a complex set of mechanisms that eliminate pathogens 
and tolerates commensal microbiota. The bacterial load is particularly dense in the intestinal 
tract where trillions of bacteria composed of hundreds of different species reside and are 
separated from the underlying immune system by a monolayer of epithelial cells. Such an 
intimate relationship facilitates the dynamic cross talk between host and microbe that underlines 
the delicate balance between tolerance and immunity in the intestines.  Compared to adaptive 
immunity, there is relatively less information available on how innate immunity is controlled in 
the intestine. 
 
The mechanisms through which innate immune responses in the intestines maybe controlled 
include the following: 
(i) Activities in the Intestinal epithelial cells (IEC): Goblet cells produce a thick layer of 
mucus and paneth cells produce bactericidal proteins that separate the luminal contents 
from the host. IEC down regulate Toll like receptor expression to remain unresponsive 
to the vast bacterial load. On the other hand, commensal bacteria enhance innate 
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immunity to pathogens by providing tonic signals (PAMPS) that are required for optimal 
immune stimulation [77]. 
(ii) Inhibition of TLR signals: TLR signaling must be tightly regulated in the intestine to 
prevent chronic stimulation by commensal microorganisms. Negative regulation 
(inhibition) is achieved at multiple levels.  
1) Interruption of TLR interaction with their ligands: This is achieved through 
decoy receptors that prevent a direct interaction between TLRs and their bacterial 
ligands [78]. For example, soluble TLR2 (sTLR2) could compete with TLR2 for 
microbial ligands and prevent the interaction between TLR2 and its ligand, and hence 
blocking TLR2 signaling. Soluble TLR2 are constitutively released by host blood 
monocytes and are naturally expressed in plasma and breast milk [79].  
2) Intracellular inhibitions: Intracellular regulators can inhibit TLR signalling pathways. 
Some of the regulators are present constitutively to control TLR activation at a 
physiological level, whereas others are up-regulated by TLR signalling during infection 
to attenuate TLR response in a negative feedback loop. Some of these regulators include 
MyD88s, IRAKM, SOCS1, and NOD2 [80-83]. 
3) Down-regulation of transcription and translation of TLR genes: These occur 
through trans-membrane protein regulators for example the suppression of 
tumorigenicity 2 (ST2), Single-immunoglobulin-IL-1R-related-molecule (SIGGIRR) 
and TNF-related apoptosis-inducing ligand (TRAIL). The absence of these receptors 
leads to down-regulation of TLR genes by decreasing the nuclear translocation of NF-
κB [84-87]. 
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4) Reduction of TLR protein: This is achieved through degradation of TLRs through 
ubiquitylation or inhibition of TLR expression by anti-inflammatory cytokines such as 
Transforming Growth Factor β (TGF-β) and IL-10 [88, 89].  
5) Inhibition by apoptosis: TLR-induced apoptosis might be important in the control of a 
dysregulated TLR response. It has been shown that interaction of TLR2 with microbial 
agonists triggered apoptosis in macrophages and epithelial cells. This interaction results 
in the recruitment of MyD88 and subsequent interaction with FAS-associated death 
domain (FADD) through its death domain. This allows the recruitment of caspase-8 to 
form the death-inducing signalling complex, which triggers the apoptotic cascade [90, 
91]. 
(iii) Regulatory Cells: Different regulatory cells including regulatory T cells (Tregs), regulatory 
B cells (Bregs) and regulatory DCs have been identified and are thought to contribute to the 
regulation of immunity in the intestines. These cells exert their influence on other cells through 
the secretion of the anti-inflammatory cytokine, IL-10 and also by secreting TGFβ. Regulatory 
T (Treg) cells are known to limit microbe-triggered intestinal inflammation [92]. Also, Tregs were 
shown to maintain intestinal homeostasis by suppressing γδ T cells in PDK1-deficient mice and 
prevented the development of colitis [93]. 
 
1.3       B lymphocyte Development 
B cells develop from hematopoietic precursor cells in an ordered maturation and 
selection process. B cells originate from hematopoietic stem cells (HSCs), and undergo several 
developmental stages including early lymphoid progenitor, common lymphoid progenitor 
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(CLP), pro-B and pre-B cells within the bone marrow, and transitional B cells in the peripheral 
lymphoid organs, before developing into mature B cells [94]. 
 
Two schemes of B cell development have been described for different species. In the 
first scheme, immunoglobulin  (Ig) locus rearranges early in ontogeny followed by a definitive 
pool of B cells that expand by a self-renewing mechanism, and they are mostly B1 type of B 
cells [95]. In the second scheme, the Ig repertoires are continuously generated from precursors 
in the bone marrow throughout life and these are composed of mostly B2 types of B cells. 
During B-cell development, the BCR promotes B-cell maturation while purging auto-reactive 
clones and sorting mature B cells into follicular I and II (FoBI and FoBII), marginal zone (MZ) 
and B1 B-cell populations [96]. Mature B cells further differentiate into effector, regulatory, 
memory and plasma cells [97]. The development of B cells begins in the bone marrow (BM) 
culminating in surface IgM (sIgM) expressing immature B cells, which then undergo further 
maturation in the spleen [97]. To safeguard against autoimmunity, immature B cells are 
subjected to central tolerance mechanisms in the bone marrow. [98] 
 
B cells in mammals are composed of several subsets with different functionalities. In 
sheep, three major B cell subsets have been identified, namely the follicular B2 cells that are 
responsible for immune responses against thymus-dependent antigens that undergo germinal 
center reactions and generate high affinity antibodies with precise antigen specificities [95, 
99]. The B1 and marginal zone (MZ) B cells respond to thymus-independent antigens and 
produce low affinity antibodies with broad re-activity [95, 99].  
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1.3.1       Activation and maturation of B lymphocytes 
Bacterial DNA can trigger direct activation of B cells. In-vivo and in-vitro studies in mice 
have shown that purified B cells can be activated with microbial PAMPs [100].  When Kurt and 
colleagues (2000) stimulated B cells with TLR9 ligand, the level of proliferation was less than 
2500 cpm but on activation through BCR, the level of proliferation increased to above 15000 
cpm [100]. This suggests that BCR signaling may be required for significant activation of B 
cells through TLR9. Therefore, there is need for 2 signals for optimal CpG B cell activation. 
This is similar to the two signal model proposed by Bretscher & Cohn over 30 years ago and 
reaffirmed by Baumgarth and Janeway [101-103].   
 
 B cell activation is initiated by the ligation of the B cell receptor (BCR) with antigen 
and ultimately results in the production of protective antibodies against pathogens [104]. The 
earliest events in B cells activation include the initiation of BCR triggering, the formation of 
BCR micro-clusters, and the dynamic regulation of BCR signalling. Antigen engagement of 
BCR leads to a cascade of events that result in antigens within endosomes being processed, 
loaded onto the major histocompatibility complex (MHC), and presented on the B cell surface 
[105, 106]. This antigen presentation allows for the recruitment of cognate CD4+ T helper cells 
to facilitate the complete activation of B cells through CD40 [105, 106]. 
 
1.3.2        Sheep PP B cells 
Sheep PP B cells can be divided into two subsets based on cell size and surface expression 
of CD21 and CD72 molecules [107]. CD21+ B cells, which are a representative of naive B cells, 
are localized in the B cell follicles of PPs, LNs and the spleen and are actively re-circulating 
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[107, 108]. We recently reported that within the PP CD21+ B cell population there are cells that 
produce IL-10 and have a regulatory function [1].  
 
CD72 is a 45-kDa type II membrane protein containing a C-type lectin like domain and includes 
other related cell surface molecules such as asialoglycoprotein receptors [109]. CD72 antigen is 
expressed on all cells of B cell lineage with the exception of plasma cells [110]. 
 
1.3.3        TLR9 in B cell activation  
Expression of Toll-like receptors (TLRs) in B cells provides a cell-intrinsic mechanism 
for innate signals regulating adaptive immune responses [111]. In combination with other 
signalling pathways in B cells, including through the B-cell receptor (BCR), TLR signalling 
plays multiple roles in B-cell differentiation and activation [112]. B-cell-intrinsic TLR 
signalling regulates antibody responses, including germinal center formation and auto 
antibody production in autoimmune disease models [112].  
 
TLR signalling also acts on the precursors of B cells, which could influence the immune 
response of animals by shaping the composition of the immune system. Transitional B cells 
can be subdivided into two separate subpopulations, termed transitional 1 (T1) and transitional 
2 (T2) B cells, based on their surface phenotype and functional characteristics [113]. TLR 
activation in transitional B cells which is also the stage for negative selection and might change 
cell differentiation routes.  Ueda et al (2007) have shown that T1 B cells could be activated by 
LPS or CpG to secrete IgM and class-switched Igs [114]. Similarly, it has been shown that 
stimulation of T1 and T2 B cells with CpG leads to secretion of pro-inflammatory cytokines 
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[115]. Carsetti and colleagues have recently shown that CpG induced human cord blood 
transitional B cells to differentiate into plasma cells with both class switching and somatic 
hyper-mutations [116].  
 
1.3.4        Cytokine secreting B cells 
There is substantial evidence that B cells do not act solely through their antibody 
secretion but also influence the course of immune responses through antibody-independent 
mechanisms. For example, B cells can be activated by TLR agonists to secrete pro-
inflammatory or anti-inflammatory cytokines [51]. It has been proposed that B cells can be 
subdivided on the basis of the cytokines they produce. B lymphocytes that secrete cytokines 
can be subdivided in two different subsets: (i) regulatory B cells (Breg), producing IL-10 or 
TGF, and (ii) Effector B cells (Be), which express distinct arrays of cytokines depending on 
their maturation stage and environment [3, 117]. B effector cells were initially classified as 
producing Th1 cytokines (Be1) or Th2 cytokines (Be2) [118, 119]. The Be1 cells secrete IL-
12 and IFN-γ whereas Be2 secrete IL-4, IL-5, IL-6, IL-10 and IL-13 [9, 120]. Although it has 
long been known that B cells produce cytokines, such as IL-10, IL-6 and TNF-α, they also 
acquire the ability to express IL-2, IFN-γ, IL-4 and IL-12 when stimulated with antigen in the 
presence of effector Th1 cells [121, 122]. 
 
1.3.5       Regulatory B cells  
The first evidence that B cells may exert suppressive activity came from early studies 
in guinea pigs in the mid-1970s. The transfer of total but not B cell-depleted splenocytes 
inhibited delayed-type hypersensitivity reactions [123]. Regulatory B cells secrete IL-10 or 
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TGFβ and are analogous to Tregs [3, 124]. Janeway and colleagues were the first to provide 
evidence for a direct regulatory role of B cells in the suppression of a T cell-mediated 
autoimmune reaction, using a mouse model (μMT – a strain genetically deficient in B cells) of 
experimentally induced autoimmune encephalomyelitis (EAE) [125, 126]. Furthermore, 
Fillatreau and colleagues demonstrated that while disease onset and severity were not affected 
by the μMT mutation, recovery was severely impaired in the absence of IL-10 producing B cells 
in IL-10 knockout mice [127]. Subsequently, Mizoguchi and colleagues coined the term 
regulatory B cells (Bregs) to designate B cells with regulatory properties, independent of secreted 
immunoglobulins [128]. These Bregs exert their regulatory activities through IL-10 production. 
While studying spontaneous colitis that develops in TCR knockout mice, Mizoguchi and Bhan 
also demonstrated that IL-10-producing B cells were responsible for suppressing the T cell-
mediated progression of chronic intestinal inflammation [122, 129]. Mann et al (2012) have 
recently confirmed that a regulatory B cell population plays an essential role in the spontaneous 
recovery from EAE, an experimental disease model for human multiple sclerosis [130]. 
Furthermore Bregs can have both protective and pathogenic roles as seen in a mouse model of 
collagen induced arthritis and EAE [122]. The negative role of B cells in down modulating 
immune responses has then been demonstrated in several murine models, but mainly in 
autoimmune encephalomyelitis [125, 127, 131].  
 
Regulatory B cells that produce IL-10 are now recognized as an important component of 
the immune system. However, other cells have been implicated in the production of IL-10 in the 
intestine, including, follicular DCs and Tregs [122]. The identification of regulatory T cells (Tr1, 
Tr3, TCD4+CD25+FoxP3+) suggested the existence of regulatory B cells (Bregs).  Several 
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studies have also shown Bregs to have a negative role in immune interactions for example a 
recent study has shown that Breg cell dysfunction contributes pivotally to the progression of 
adipose tissue inflammation in obesity in mice [132]. Bregs are also potent negative regulators of 
antigen-specific inflammation and T-cell-dependent autoimmune diseases in mice [133-135]. 
 
1.3.6        Peyer’s patches regulatory B cells 
 Recently, a novel regulatory B cell that secretes IL-10 and does not secrete IL-12, IFN-
α, IFN-γ and IgM and does not proliferate when stimulated with CpG ODN was discovered in 
sheep Peyer’s patches [1, 76]. In chapter 3 of this thesis, we show that these PP Bregs  develop 
in utero prior to antigen exposure  [76]. In subsequent chapters of this thesis, we show that 
Bregs are present in various tissues and we also show that these Bregs are present in the jejunal 
PP of newborn cattle. 
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CHAPTER 2: RATIONALE, HYPOTHESIS, OVERALL OBJECTIVE AND AIMS. 
 
2.1 Rationale and hypothesis 
The innate immune system uses a variety of germ-line encoded receptors collectively 
referred to as pathogen recognition receptors (PRR) to detect the presence of microbial 
agents. The best known of these are Toll-like receptors (TLRs) which play a critical role in 
the initiation, development and regulation of innate and adaptive immune responses. The 
gastrointestinal tract expresses these receptors and is constantly exposed to diverse 
commensal microbiome. Innate immune recognition in the intestine must be well regulated 
to prevent unwanted inflammation against harmless food antigens and commensal bacteria 
and yet allow the induction of protective immunity to pathogens. A dysregulation of this 
balance results in abnormal immune responses leading to intestinal inflammation. Peyer’s 
patches (PP) are the primary site for the induction of immune responses in the intestine and 
cells in PPs express TLRs. Since the intestine harbours many commensal organisms, it 
therefore makes sense that TLR responses be appropriately regulated in this tissue. 
 
Regulatory B cells (Bregs) are known to regulate immune responses through the 
secretion of the cytokine, IL-10. Bregs have recently been described in jejunal PP of sheep [1]. 
However it is not known when Bregs develop, whether they exist in other lymphoid tissues or 
whether they exist in other ruminant species. 
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Hypothesis:  
1. Bregs in PP develop prior to birth and are distributed in variety of mucosal and 
systemic lymphoid tissues of ruminants. 
2. B cells in PP exist in two distinct populations as Regulatory and Effector B cells. 
 
2.2 Overall Objective 
Our overall objective was to characterize regulatory B cells (Bregs) by addressing the 
following specific Aims 
 
2.3 Aims 
1. Investigate Bregs development in fetal and neonatal lambs. 
2. Define functional subsets of B cell populations in PP (Regulatory vs Effector B cells) 
3. Determine whether Bregs expressing surface IgM+, IgA+ and IgG1+ secrete IL-10. 
4. Survey distribution of Bregs in mucosal and systemic lymphoid tissues. 
5.  Examine whether Bregs exist in other ruminant species. 
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CHAPTER 3: IL-10 SECRETING CD21+ B CELLS ARE PRESENT IN SHEEP 
JEJUNAL PEYER’S PATCHES DURING FETAL DEVELOPMENT 
(Article published in Cell and Tissue Research, 2014 [76]) 
 
Relationship of this study to the dissertation. 
 
Regulatory B cells (Bregs) are known to regulate immune responses through the 
secretion of the cytokine, IL-10. Studies in our laboratory have recently described Bregs in 
jejunal PP of sheep [1]. However it is not known when Bregs develop in sheep. We therefore 
sought to study the development of CD21+ regulatory B cells in Peyer’s patches of sheep. 
These studies suggest that Bregs develop in utero prior to birth and are present in young lambs. 
 
3.1 Abstract 
We recently reported a novel IL-10-secreting CD21+ B cell population in jejunal Peyer’s 
patches (PP) of sheep with a regulatory function (Bregs) which suppresses TLR9-induced 
cytokine responses. However, little is known about the development of these cells. Therefore, 
we investigated the existence of these IL-10-secreting Bregs in jejunal PP cells from fetal and 
newborn lambs. CD21+ B cells were purified from jejunal PP cells by magnetic cell sorting 
and subsequently stimulated with the TLR9-agonist, CpG ODN (CpG oligodeoxynucleotide). 
Lymphocyte proliferative responses, cytokine production (IL-10, IL-12 and INF γ), and 
antibody secretion were assayed. We observed that fetal and neonatal CD21+ B cells 
spontaneously secreted high levels of IL-10 regardless of CpG stimulation, but these cells did 
not produce any IL-12 or IFN-γ upon stimulation with CpG. These observed responses are 
consistent with those previously reported for Bregs characterized in PP of older lambs. 
Surprisingly, unlike in older lambs, fetal and neonatal PP CD21+ B cells proliferated in 
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response to CpG stimulation. Our investigations of fetal and neonatal lambs provide evidence 
for the development of IL-10-secreting CD21+ B cells in Peyer’s patches prior to antigen 
exposure. 
 
Key words: Immune regulation; regulatory cells; Bregs; Peyer’s patches; TLR9; CpG ODN; 
sheep. 
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3.2 Introduction 
B cells can be divided into two classes according to their functional characteristics; the 
effector and regulatory B cells. Effector B cells are positive regulators of immune responses 
and can be further subdivided into two distinct cytokine-secreting subsets, B-effector-1 cells 
(Be1) and B-effector-2 (Be2) [9, 136]. The Be1 cells produce a Th-1-like cytokine pattern 
(IL-12 and IFN-γ) and Be2 produce a Th-2-like cytokine pattern (IL-4, IL-5, IL-6, IL-10 and 
IL-13 [9, 120]. These cells function as antibody producing cells, present antigens to T cells 
and modulate T cell-mediated responses [137]. These cells terminally differentiate into 
plasma cells that are tasked with the production of different antibodies [138]. 
 
 B cells with regulatory functions have been recently described. Janeway and 
colleagues were the first to provide evidence for a direct regulatory role of B cells in the 
suppression of a T cell-mediated autoimmune reaction, using a mouse model (μMT – a strain 
genetically deficient in B cells) of experimentally induced autoimmune encephalomyelitis 
(EAE) [125, 126]. Furthermore, Fillatreau and colleagues demonstrated that while disease 
onset and severity were not affected by the μMT mutation, recovery was severely impaired 
in the absence of IL-10 producing B cells in IL-10 knockout mice [127]. Subsequently, 
Mizoguchi and colleagues coined the term regulatory B cells (Bregs) to designate B cells with 
regulatory properties independent of secreted immunoglobulins [128]. These Bregs exert their 
regulatory activities through IL-10 production. While studying spontaneous colitis that 
develops in TCR knockout mice, Mizoguchi and Bhan also demonstrated that IL-10-
producing B cells were responsible for suppressing the T cell-mediated progression of 
chronic intestinal inflammation [122, 129]. Mann et al (2012) have recently confirmed that a 
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regulatory B cell population plays an essential role in the spontaneous recovery from EAE, 
an experimental disease model for human multiple sclerosis [130]. Furthermore, Breg cells can 
have both protective and pathogenic roles as seen in a mouse model of collagen induced 
arthritis and EAE [122] . The species of choice for studying these Breg cells has been mice. 
However, in mice Bregs only exist in disease models or are induced but do not occur 
spontaneously.  
 
Recent investigations in our laboratory with sheep have identified a novel B cell 
population in jejunal Peyer’s patches with regulatory function (Bregs) that spontaneously 
produce IL-10 and suppresses TLR9-induced IFN-γ and IL-12 cytokine responses [1]. This 
B cell population is CD5-, CD11c- and CD21+ [1]. The difference between Bregs described by 
others and the Bregs described by our group is that sheep Peyer’s patch Bregs exist in a normal 
disease-free condition and spontaneously secretes high levels of IL-10, while the Bregs 
reported by others only occur during intestinal inflammation or colitis [128]. However, little 
is known regarding the development of Bregs in sheep and other species. Since, the intestine 
is subjected to many changes after birth due to exposure to dietary antigens and colonization 
by the commensal flora, we investigated whether post-natal changes in the intestine 
influenced Bregs development and function in the JPP.  Here, we describe investigations 
regarding the ontogeny of IL-10 producing B cells. In particular, we determined when sheep 
Peyer’s patch Bregs develop and whether there are any differences between fetal, neonatal and 
adult sheep Peyer’s patch IL-10- producing B cells. 
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3.3.  Materials and methods 
3.3.1 Animals 
Suffolk sheep of either sex were obtained from the Department of Animal and Poultry 
Science (University of Saskatchewan, Saskatoon, SK, Canada).  3rd trimester foetuses, 
newborn (1-4 days old) and 2-4 months old lambs were used in these studies. Experiments 
were conducted according to the Guide to the Care and Use of Experimental Animals, 
provided by the Canadian Council on Animal Care. All experimental protocols were 
approved by the University of Saskatchewan Animal Care Committee.  
 
3.3.2 CpG Oligodeoxynucleotides 
Oligodeoxynucleotides of different classes have been shown to be biologically active 
in sheep both in vitro and in vivo. We used B-class CpG ODN 2007 to stimulate cells in our 
experiments. The CpG ODN 2007 and CpG ODN 2007 GC were obtained from Merial 
Limited (Lyon, France). They have the following sequences and backbone structures; 2007 
B tcgtcgttgtcgttttgtcgtt and 2007GC B tgctgcttgtgcttttgtgctt. The ODN doses were previously 
optimized and used at a dose of 5ug/ml [1, 139]. 
 
3.3.3 Enzyme-linked immunosorbent assay (ELISA) for IFN-γ, IL-12 and IL-10 
Polystyrene microtiter plates were coated with capture antibody as follows; for IL-10, 
Mouse anti-recombinant bovine IL-10 CC318 (Serotec MCA 2110) was diluted to 0.5 μg/mL  
in coating buffer, for IL-12, mouse anti-recombinant bovine IL-12 antibody (Serotec MCA 
1782EL, NC, USA) was diluted to 8 μg/mL in coating buffer. For the IFN-γ ELISA, mouse 
anti-bovine IFN-γ antibody (clone 2-2-1A) was used in coating plates. Plates were then 
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incubated overnight at 4oc in the refrigerator. Plates were then washed four times with Tris 
buffered saline /0.05% Tween 20 (Sigma-Aldrich) (TBST). Recombinant bovine IL-10 [140], 
recombinant bovine IFN-γ (bIFN-γ) and recombinant human IL-12 (rHuIL-12) (Serotec PHP 
100) were used as standards to measure cytokine concentration. Standards and samples were 
diluted in TBST/0.5% gelatin (Sigma-Aldrich) (TBST-g) and added to the wells at 2 fold 
dilutions. To detect bound cytokine, Mouse anti bovine IL-10 CC320 biotin (Serotec MCA 
2111B) for IL-10, rabbit anti-bovine IFN-γ antisera followed by  biotinylated goat anti-rabbit 
IgG (Zymed, South San Fransisco, CA, USA) for IFN-γ and mouse anti-bovine IL-12 CC326 
biotin (Serotec MCA 2173B) were added. Next, streptavidin-alkaline phosphatase 
(GibcoBRL) was used for detection of the bound biotinylated antibodies. The assay was then 
developed by using p-nitrophenyl phosphate (Sigma-Aldrich) substrate in 1 % 
diethanolamine (Sigma-Aldrich) and 0.5 mg/mL magnesium chloride. The reaction was 
stopped by adding EDTA to each well. Optical density of the reaction product was measured 
at 405 nm using a 490 nm reference on a Benchmark microplate reader (Bio-Rad 
Laboratories, Hercules, CA, USA). The sample concentrations were calculated using 
Microplate Manager 5.0.1 version software (Bio-Rad). U/ml (units per ml) for IL-10 was 
defined previously by Kwong et al [140], as the biological activity of IL-10 with one unit 
being the reciprocal of the IL-10 dilution that inhibited IFN-γ secretion by 50 % of Cos-7 
cells. 
 
3.3.4  Isolation of JPP cells 
Lambs were euthanised and JPP tissues immediately removed and placed in ice-cold 
DMEM (GibcoBRL) containing antibiotics (100 U/mL), Penicillin, 100 μg/mL Streptomycin 
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sulphate and 0.25 μg/mL Amphotericin B (Sigma-Aldrich). JPP cells were isolated from 
lambs as described previously [141]. The number of viable cells isolated from all tissues was 
determined by trypan blue dye exclusion and viable cells were counted with a hemocytometer 
under a light microscope. Cells were re-suspended at the appropriate concentrations in AIM 
V medium, (Medium supplemented with 2% FBS, 100U/mL penicillin, 100 μg/mL 
streptomycin sulfate, 0.25 μg/mL amphotericin B, 2Mm L-glutamine, 50 μM 2-
mercaptoethanol and 10 μg/mL polymyxin B sulfate (Sigma- Aldrich) and added to round 
bottomed 96-well plates (Nunc, Naperville, IL, USA).   
 
3.3.5 Magnetic activated cell sorting (MACS) 
JPP cells were stained with mouse anti-bovine CD21 (IgG1 isotype; AbD Serotec, UK) 
for 15 min at 40C. The JPP cells were then washed twice with MACS buffer (PBSA, 0.5M 
EDTA and 10% BSA) which was followed by centrifugation for 8 min at 440 x g. The JPP 
cells were then stained with goat anti-mouse IgG1 phycoerythrin (PE) conjugate (ABD 
Serotec, UK) for 15 min at 40C before washing as above. The JPP cells were then labelled 
with anti-PE magnetic beads for 15 min at 40C and passed through the LC MACS column 
(Miltenyi Biotec, Bergish Gladbach, Germany) according to manufacturer’s instruction. The 
CD21+ B cell fraction was eluted, washed in PBSA and re-suspended in AIM V medium. 
Cell purity was assessed by flow cytometry and was consistently greater than 98%. 
 
3.3.6 Tissue culture conditions and stimulation with TLR agonists 
Isolated CD21+ cells were re-suspended in AIM V medium. Aliquots of 5x105 cells for 
CD21+ and 3×105 for CD21- cells were cultured in triplicate wells in a final volume of 200 
μL. Cells were stimulated with TLR9 agonists B-class CpG 2007 or GpC 2007 as a control 
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at 5 μg/mL and then incubated at 37°C in a 5% CO2 atmosphere and 95% humidity. For 
optimal detection of cytokines, cells were stimulated for 48 hrs as previously described [141]. 
Culture supernatants were stored at -20oC until assayed for secreted cytokines. 
 
3.3.7 Lymphocyte Proliferative responses 
CD21+ cells isolated by MACS were plated in triplicate cultures at 2.5 x 105 cells per 
well in a final volume of 200 μL. The cells were stimulated and incubated as described above 
before pulsing each well with 0.4 μCi 3H-Thymidine (Amersham Pharmacia, Piscataway, NJ) 
during the final 6 hrs of the 72 hrs incubation. Cells were then harvested using standard liquid 
scintillation protocols. The uptake of 3H-Thymidine was assessed in a beta counter 
(Topcount, Packard Instrument Company, Meriden, CT). The proliferation of the cells was 
calculated as the mean counts per minute (cpm) of triplicate cultures and expressed as a 
stimulation index (cpm in the presence of stimulus/cpm in the absence of stimulus). 
 
3.3.8 Statistical analysis 
Data analysis was performed with the statistical software program, Graph Prism 5 
(Graphpad software). Data that were not normally distributed were transformed by ranking. 
Individual group differences were examined by performing one way analysis of variance 
(ANOVA). Values of p<0.05 and p<0.01, were considered significant and very significant 
respectively. Kruskal-Wallis test and Dunn’s test was used to perform the post-hoc tests. 
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3.4 RESULTS 
3.4.1  IL-10 production 
 Previous investigations in our laboratory have shown that a regulatory B cell (Bregs) 
population exists in jejunal PPs of 3-4 month old lambs and when cultured these Bregs 
spontaneously secrete high levels of IL-10 [1].  However, it is not known when these Bregs 
first develop and whether they are present in fetal or neonatal lambs. We therefore carried out 
experiments to determine whether Breg activity could be detected in fetal and neonatal lambs 
and to confirm our earlier observations with 3-4 month old lambs. 
 
 IL-10 production was assayed in culture supernatants from cells isolated from JPP 
tissues of 3-4 month old lambs. Spontaneous IL-10 secretion by the total JPP cell population 
was increased following stimulation with CpG (Fig 1a). Similarly, enriched JPP CD21+ B 
cells spontaneously secreted IL-10, but IL-10 secretion was not significantly increased 
following CpG ODN stimulation (Fig 1a). There was, however, no IL-10 secretion by CD21- 
cells, with or without CpG stimulation. These results are consistent with our previous 
observations for PP cells isolated from this age group of lambs [1]. 
 
We then investigated IL-10 secretion by PP cells isolated from neonatal lambs (1-4 
days old). Both total JPP cells and enriched CD21+ B cells spontaneously produced IL-10 
and CpG stimulation increased IL-10 secretion by these two cell populations. Thus, CD21+ 
B cells secreted IL-10 regardless of stimulation with CpG (Fig 1b). Again, IL-10 secretion 
was not detected in either the stimulated or unstimulated CD21- cells.  
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Similar results were observed following the isolation of jejunal PP cells from third 
trimester fetal lambs. Unstimulated JPP cells and enriched CD21+ B cells both secreted IL-
10 spontaneously and stimulation with CpG ODN did not significantly increase IL-10 
secretion (Fig. 1c). Furthermore, no IL-10 secretion was detected in the fetal jejunal PP CD21- 
cells (Fig.1c). Therefore, unstimulated CD21+ B cells from fetal, neonatal and 3 month old 
lambs all secrete IL-10, indicating that IL-10 secreting CD21+ B cells develop prior to birth.  
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 Figure 1. Interleukin (IL)-10 production in JPP cells from adult (a), neonatal (b) and foetal 
lambs (c). Unfractionated jejunal PP (JPP), JPP CD21+ B cells and JPP CD21- cells were 
cultured for 48 hours in medium alone, or in the presence of 5 µg/ml of CpG or GpC ODN. 
IL-10 production was evaluated in the culture supernatants by IL-10 ELISA. Data for 
individual animals are presented with mean value indicated by horizontal bar for each group 
(n=5).  
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3.4.2 IL-12 production 
In our previous investigation, Bregs from PP from sheep were characterised by the 
production of IL-10 but not IL-12 or IFN-γ [1]. Therefore, we evaluated the production of 
the cytokine, IL-12 in CD21+ B cells. In 3-4 month old lambs, there were low levels of 
spontaneous IL-12 secretion by JPP cells (Fig. 2a) but these levels did not increase 
significantly following CpG ODN stimulation. There was no detectable IL-12 secretion 
by the enriched CD21+ B cells with or without CpG ODN stimulation which is consistent 
with previous observations [1]. In contrast, CD21- cells increased IL-12 secretion 
following CpG ODN stimulation but this increase was not significant (Fig. 2a).  
 
Significant IL-12 secretion was also detected in both neonatal JPP cells and CD21- 
populations but IL-12 secretion was not significantly changed by CpG ODN stimulation 
(Fig. 2b). No IL-12 secretion was detected in the enriched CD21+ B cell population, with 
or without CpG ODN stimulation.  
 
JPP cells isolated from fetal lambs spontaneously secreted IL-12 and the IL-12 
secretion was again increased following CpG stimulation. Enriched CD21+ B cells did not 
secrete detectable IL-12, with or without CpG ODN stimulation. In contrast, CD21- PP 
cells spontaneously secreted low but detectable levels of IL-12 and this response 
increased significantly following CpG ODN stimulation (Fig. 2c). Therefore, CD21+ B 
cells from fetal, neonatal and 3-4 month old lambs do not secrete IL-12, with or without 
CpG ODN stimulation. 
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Figure 2.  Interleukin (IL)-12 production in JPP cells from adult (a), neonatal (b) and foetal 
lambs (c). Total jejunal PP (JPP), JPP CD21+ B cells and JPP CD21- cells were cultured for 
48 hours in medium alone, or in the presence of 5 µg/ml of CpG or GpC ODN. IL-12 
production was evaluated in the culture supernatants by IL-12 ELISA. Data for individual 
animals are presented with mean value indicated by horizontal bar for each group (n=5). 
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3.4.3 IFN-γ production 
In 3-4 month old lambs, there were low levels of IFN-γ secretion by the 
unstimulated total JPP population (Fig. 3a). These levels did not significantly change 
following stimulation with CpG. There was no IFN-γ secretion in the enriched CD21+ B 
cell population even after stimulation with CpG ODN, which is consistent with our 
previous observations [1].  There was significant production of IFN-γ in the CD21- 
population though these levels did not increase following stimulation with CpG (Fig. 3a).  
 
In neonatal lambs, significant IFN-γ was detected in the total JPP and the CD21- 
populations and this response was increased on stimulation with CpG (Fig. 3b). However 
there was no IFN-γ production in the CD21+ population even after CpG stimulation.  
 
In the fetal lambs, there was essentially no production of IFN-γ in the CD21+ B cells 
population (Fig. 3c).  In contrast, there was significant IFN-γ production by the unstimulated 
CD21- cell fraction and this improved after stimulation with CpG. Surprisingly, no IFN-γ was 
detected in the total JPP cell population. 
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 Figure 3.  IFN-γ production in JPP cells from adult (a), neonatal (b) and foetal lambs (c). 
Total jejunal PP (JPP), JPP CD21+ B cells and JPP CD21- cells were cultured for 48 hours in 
medium alone, or in the presence of 5 µg/ml of CpG or GpC ODN. IFN-γ production was 
evaluated in the culture supernatants by IFN-γ ELISA. Data for individual animals are 
presented with mean value indicated by horizontal bar for each group (n=5).  
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3.4.4 IgM production 
We then evaluated IgM secretion from JPP cells of 3-4 month old lambs. JPP cells 
spontaneously secreted IgM but CpG ODN stimulation did not alter this response (Fig. 4a). 
There was, however, no detectable IgM secretion by enriched CD21+ cells, either with or 
without CpG ODN stimulation (Fig. 4a). These observations are consistent with our previous 
report [1] with the exception that significant spontaneous IgM secretion was detected for the 
CD21- cells.  
 
A similar IgM secretion pattern was observed for neonatal JPP cells and enriched 
CD21+ B cells (Fig. 4b) with the single difference that CD21- PP cells did secrete significant 
levels of IgM following CpG ODN stimulation. The pattern of IgM secretion was also 
repeated with fetal JPP cells and enriched CD21+ B cells (Fig. 4c) and there was significant 
IgM secretion by the CD21- cells (Fig. 4b).  
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Figure 4.  IgM production in JPP cells from adult (a), neonatal (b) and foetal lambs (c). Total 
jejunal PP (JPP), JPP CD21+ B cells and JPP CD21- cells were cultured for 48 hours in 
medium alone, or in the presence of 5 µg/ml of CpG or GpC ODN. IgM production was 
evaluated in the culture supernatants by IgM ELISA. Data for individual animals are 
presented with mean value indicated by horizontal bar for each group (n=5).  
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3.4.5 Lymphocyte Proliferation 
Proliferation responses of CD21+ and CD21- PP cells were assayed with cells 
isolated from lambs of different ages. As expected, PP cells from 3-4 month old lambs 
displayed significant proliferation when stimulated with either CpG or GpC control (Table 
1).  CD21- PP cells also proliferated significantly following both CpG and GpC ODN 
stimulation, although this response was low. In contrast, CD21+ B cells did not proliferate 
following either CpG or GpC stimulation (Table 2).   
 
 Neonatal JPP cells also proliferated significantly following CpG ODN 
stimulation. The CD21- PP cells did not proliferate following stimulation with CpG but, 
surprisingly, enriched CD21+ B cells displayed significant proliferation following CpG 
stimulation (Table 2).  This B cell response was distinct from earlier observations made 
with B cells isolated from 2 to 3 month old lambs. We did observe, however, spontaneous 
proliferation of fetal JPP cells and purified CD21+ B cells displayed CpG ODN-specific 
proliferation. Thus, unlike B cell responses in 3-4 month old lambs, fetal and neonatal 
CD21+ B cells proliferated following CpG. ODN stimulation. 
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 Fetal (Mean ± SD) Neonatal (Mean ± SD) 3-4 month old (Mean ± SD) 
Total JPP media 1 1 1 
Total JPP CpG 6.59 (±7.45) 13.12 (±11.65) 3.83 (± 0.88) 
Total JPP GpC 0.974 (±0.42) 1.24 (±0.89) 4.29 (± 3.23) 
Total CD21+ Media 1 1 1 
Total CD21+ CpG 6.04 (±7.11) 10.20 (±12.06) 1.41 (± 0.51) 
Total CD21+ GpC 2.90 (±1.34) 0.86 (±0.95) 0.70 (± 0.41) 
Total CD21- Media 1 1 1 
Total CD21- CpG 3.55 (±2.57) 1.10 (±0.67) 3.13 (± 1.93) 
Total CD21- GpC 1.71 (±1.36) 0.77 (±0.47) 2.50 (± 0.68) 
 
S.I values of ≥2.5 are considered to be significant compared to media. 
 
Table 2.  Proliferation in JPP cells from adult (a), neonatal (b) and foetal lambs (c). Total 
jejunal PP (JPP), JPP CD21+ B cells and JPP CD21- cells were cultured for 66 hours in 
medium alone, or in the presence of 5 µg/ml of CpG or GpC ODN. Radioactive thymidine 
was then added in the cultures and cells incubated for an extra 6hours. Proliferation of the 
different cell groups was then carried out. Data for individual animals are presented with 
mean value indicated by horizontal bar for each group (n=5).  
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3.5. Discussion 
We investigated the development of IL-10 producing regulatory B cells, that we have 
previously shown to exist in 3-4 months old lambs [1]. These investigations confirmed that 
IL-10 secreting Bregs are also detectable in JPP of fetal and neonatal lambs.  
 
 Sheep B cells can be divided into two subsets based on cell size and surface 
expression of CD21 and CD72 [107]. CD21+ B cells, which are a representative of naive B 
cells, are localized in the B cell follicles of PPs, LNs and the spleen and are actively re-
circulating [107, 108]. We recently reported that within the PP CD21+ B cell population there 
are cells that produce IL-10 and have a regulatory function [1].  
 
Like their T cell counterparts, Bregs cells are capable of inhibiting inflammatory 
responses and inducing immune tolerance through the production of IL-10 and TGFβ [3, 
142]. IL-10 is an immune regulatory cytokine with pleiotropic functions, including 
suppression of inflammation [143]. IL-10 is produced by different cells including B cells, 
Tregs, monocytes, macrophage, neutrophils and DCs. It has been convincingly demonstrated 
that IL-10-producing B cells can suppress inflammatory responses in colitis, collagen induced 
arthritis and in experimental autoimmune encephalomyelitis [122, 127, 131]. IL-10 mediates 
suppression of inflammation by several mechanisms, including down regulation of the 
production of proinflammatory cytokines, such as IL-6, IL-12, IL-17, IL-18, IFN-γ, TNFα 
and the expression of MHC class II [143-145]. We have previously reported that PP Bregs 
from 4 month old lambs secrete IL-10 which suppresses production of IL-12, IFN- γ and IFN-
α [1]. In the present investigation, we show that both neonatal and fetal CD21+ B cells also 
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secrete IL-10 and presumably have a regulatory function. The significance of the presence of 
IL-10 producing CD21+ B cells is not clear but implies that there is a competent mucosal 
immune system present at birth to protect the newborn against unnecessary inflammatory 
responses induced by enteric flora. 
 
The CD21- cells in this experiment are made up of CD21-CD72+ B cells, CD21-CD72- 
B cells, T cells, Dendritic cells and Macrophages [146]. Follicular dendritic (FDC) cells are 
also present in PP.  FDC play a role during the selection of memory B lymphocytes during a 
germinal center reaction [147] [148]. They have been shown to express the CD21 marker 
[149, 150]. However, FDC express the SCR10a-containing CD21L, while B cells selectively 
express the short CR2/CD21 lacking exon 10a (CD21S) [150]. It is unlikely that the FDC that 
expressed CD21 produced IL-10 since we have negatively sorted B cells and shown that only 
B cells produce IL-10 (Jimbo et al, manuscript in preparation).  
 
CD21+ B cells isolated from fetal PPs would not have been exposed to exogenous 
antigens and yet they produced detectable levels of IL-10. This implies that PP Bregs 
production of IL-10 is antigen-independent and is therefore spontaneous. Therefore, PP may 
function as a site for the production of natural Bregs analogous to the thymus which functions 
as a site for natural Treg generation [151]. Peyer’s patches are the primary mucosa-associated 
immune induction sites in the small intestine [69]. We previously reported that jejunal PP 
cells produced low levels of IFN-γ, IL-12 and IFN-α and when IL-10 was neutralized in-vitro 
with an anti-IL-10 antibody, then IFN-γ and IL-12 responses were elevated [1]. Presumably 
the suppressive effects of IL-10 produced by PP CD21+ B cells dampens potentially harmful 
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inflammatory responses (e.g. IL-12 and IFN-γ) in response to CpG-DNA from commensal 
microflora in the intestine. This suppressive effect in fetuses may be present to ready the 
system for the colonization of the gut lumen with different microbiota at birth.  We were 
however not able to carry out further experiments to evaluate the suppressive ability of the 
PP CD21+ in the fetal lambs due to the limited number of isolated cells. We therefore focussed 
on assessing their existence in this age group. 
 
IL-12 is a pro-inflammatory cytokine that influences development of Th-1 type 
responses. It is produced primarily by monocytes, macrophages and dendritic cells following 
microbial stimulation, whereas T cells and NK cells are the major responders to IL-12. The 
T cells and NK cells act by up-regulating IFN-γ production, proliferation and cytotoxic 
activity [152]. In the present study, IL-12 was produced in jejunal PP cell population but not 
in CD21+ B cells population (Bregs). Similarly, Bregs did not produce IFN-γ. Therefore, PP 
Bregs secrete immunoregulatory IL-10 but not the pro-inflammatory cytokines, IL-12 and 
IFN-γ. This observation is consistent with the concept that CD21+ B cells include a regulatory 
B cell subpopulation. 
 
Sheep B cells from blood produce IgM and proliferate in response to CpG stimulation 
[2]. However, it has also been shown that CD21+ Bregs isolated from sheep PP do not secrete 
IgM or proliferate following CpG ODN stimulation [2]. This lack of CpG-specific responses 
was attributed to a unique pattern of TLR9 signal transduction that was attributed to a defect 
in the signalling transduction pathway downstream of TLR9 [2]. In our present study, we 
observed that CD21+ B cells isolated from the jejunal PP of older lambs do not proliferate, 
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results that were consistent with earlier observations [1]. In contrast, we observed that CD21+ 
B cells isolated from the PPs of fetal and neonatal lambs did proliferate following CpG ODN 
stimulation.  Therefore, we hypothesize that the proliferation of PP B cells in fetal and 
neonatal lambs may be attributed to the fact that at these early stages of development the B 
cells do not have a defect in the TLR9 signal transduction pathway as reported for older lambs 
[2]. The other possibility may be technical; maybe a population of fetal and neonatal CD21- 
B cells (capable of proliferating), co-purify with CD21+. Alternatively, there may be 
insufficient Breg activity to block CpG ODN stimulation. Further investigations are required 
to determine the reason why fetal and neonatal CD21+ B cells proliferate in response to CpG 
ODN stimulation and to determine if the naturally occurring Bregs have the capacity to 
influence either T or B cell responses. 
 
In conclusion, the present investigations confirmed that B cells, spontaneously 
secreting IL-10, are present in both fetal and newborn lamb jejunal PPs.  These observations 
support the conclusion that naturally occurring Bregs develop in mucosa-associated lymphoid 
tissue in an antigen-independent manner.  
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CHAPTER 4: EVIDENCE FOR THE EXISTENCE OF REGULATORY AND 
EFFECTOR B CELL POPULATIONS IN PEYER’S PATCHES OF SHEEP 
 
Relationship of this study to the dissertation. 
 
In chapter 3 we showed that Bregs develop in utero prior to birth and are present in young 
lambs of different ages. Hence in this study, we sought to determine whether CD21+ B cells 
are the only source of IL-10 in Peyer’s patches. We also wondered whether an effector B cell 
population co-existed with regulatory B cells in the PPs. Furthermore, we sought to find out 
whether IL-10 secretion was limited to naïve CD21+IgM+ B cells, or B cells that had isotype 
switched could also secrete IL-10, whether they exist in other lymphoid tissues or whether 
they exist in other ruminant species. 
 
4.1 ABSTRACT  
IL-10 secreting CD21+ B exist in sheep Peyer’s patches (PP). It’s not known however, 
whether all PP B are regulatory or whether an effector population also exists in this tissue. To 
further characterize the subpopulations of B cells in PP’s, highly purified B cells were 
negatively sorted from jejunal PP and fractionated according to co-expression of 
CD72+CD21+or CD72+CD21- molecules and then stimulated with the TLR9-agonist, CpG 
ODN. IL-10, IL-12, IFN-γ, and IgM production were then assayed. We observed that only 
highly purified CD72+CD21+ B cells spontaneously secreted high levels of IL-10, but they 
did not produce any IL-12, IFN-γ or IgM suggesting that this cell population contains 
regulatory B cells. In contrast, CD72+CD21- B cells did not secrete IL-10, but secreted IL-
12, IFN-γ, and IgM, suggesting they include effector cells. In addition, B cells expressing 
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surface IgA, IgM and IgG1 all secreted similar levels of IL-10. We further confirmed that 
only B cells produce IL-10, while other cells in the PP including DCs and T cells do not. Our 
investigations provide evidence for the existence of two B cell sub-populations in sheep PP; 
IL-10 secreting regulatory (CD72+CD21+) cells, and IL-12/ IFN-γ/ IgM-secreting effector 
(CD72+CD21-) cells. 
Key words: Immune regulation; regulatory cells; Bregs; effector B cells; Peyer’s patches; 
TLR9; CpG ODN 
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4.2 INTRODUCTION 
 B cells are functionally characterized by the ability to produce antibodies [3]. They 
also have the capacity to produce cytokines and function as antigen presenting cells (APC) 
[3]. Based on their function, B cells can be divided into two subgroups; effector and 
regulatory B cells.  
 
Effector B cells are positive regulators of immunity and based on their cytokine 
secretion patterns have been subdivided into B-effector-1 cells (Be1) and B-effector-2 (Be2) 
[9, 136]. The Be1 cells secrete IL-12 and IFN-γ, whereas Be2 secrete IL-4, IL-5, IL-6, IL-10 
and IL-13 [9]. In addition, effector B cells function as antibody producing cells, present 
antigens to T cells and modulate T cell-mediated responses [137]. Effector B cells eventually 
differentiate into plasma cells, able to  produce  different isotype antibodies [138]. 
 
The regulatory role of B cells was first reported by Janeway and colleagues in a 
murine model of experimental autoimmune encephalomyelitis (EAE) [125]. Using a B cell 
deficient model, they reported that B cells were not required for the induction of EAE but 
they contributed to immune regulation resulting in complete recovery from acute EAE. 
Further evidence for the existence of Bregs,  was obtained from mouse models of 
inflammatory bowel disease (IBD) [122, 153], EAE [127], arthritis [131], and lupus [154, 
155]. These Bregs inhibited the progression of inflammation and/or hastened the recovery from 
the experimental inflammatory conditions. Notably, Bregs cells produce IL-10, the immuno-
regulatory cytokine that can suppress harmful immune responses by regulating Th1/Th2 
balance and directly dampening innate cell-mediated inflammatory responses [156-158]. 
46 
 
Recent investigations in our laboratory revealed a novel B cell population in sheep 
jejunal Peyer’s patches with regulatory function (Bregs) that spontaneously produce IL-10 and 
suppresses TLR9-induced IFN-γ and IL-12 cytokine responses [1]. We have subsequently 
obtained evidence that these regulatory B cells develop in utero prior to antigen exposure 
(Jimbo et al. 2014). In these previous studies, CD21+ B cells were isolated using magnetic 
cells sorting, raising questions as to whether other contaminating cell types may be present. 
In the present investigation, we sought to determine whether CD21+ B cells are the only 
source of IL-10 in Peyer’s patches. We also investigated whether an effector B cell population 
co-existed with regulatory B cells in the PPs. Furthermore, we also investigated whether IL-
10 secretion was limited to naïve CD21+IgM+ B cells, or B cells that had undergone isotype 
switching.   
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4.3 Materials and methods 
 
4.3.1 Animals and oligonucleotides 
Suffolk sheep of either sex were obtained from the Department of Animal and Poultry 
Science (University of Saskatchewan, Saskatoon, SK, Canada). 2-4 months old lambs were 
used in these studies. Experiments were conducted according to the Guide to the Care and 
Use of Experimental Animals, provided by the Canadian Council on Animal Care. All the 
experimental protocols were approved by the University of Saskatchewan Animal Care 
Committee.  
 
4.3.2 Oligodeoxynucleotides 
Oligodeoxynucleotides of different classes have been shown to be biologically active in sheep 
both in vitro and in vivo. We used B-class CpG ODN 2007 to stimulate cells in our 
experiments. The CpG ODN 2007 and GpC ODN 2007 GC were obtained from Merial 
Limited (Lyon, France). They have the following sequences and backbone structures; 2007 
tcgtcgttgtcgttttgtcgtt and 2007GC tgctgcttgtgcttttgtgctt. The ODN doses were previously 
optimized and used at a dose of 5ug/ml [1, 139]. 
 
4.3.3 Isolation of JPP cells for culture 
Lambs were euthanized and jejunal Peyer’s patch (JPP) tissues immediately removed and 
placed in ice-cold DMEM (GibcoBRL) containing antibiotics (100 U/mL), Penicillin, 100 
μg/mL Streptomycin sulfate, 0.25 μg/mL Amphotericin B (Sigma-Aldrich).  Cells were 
isolated from JPP as described previously [141]. The number of viable cells isolated from all 
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tissues was determined by trypan blue dye exclusion and viable cells were counted with a 
hemocytometer under a light microscope. Cells were re-suspended at the appropriate 
concentrations in AIM V medium (supplemented with 2% FBS, 100U/mL penicillin, 100 
μg/mL streptomycin sulfate, 0.25 μg/mL amphotericin B, 2Mm L-glutamine, 50 μM 2-
mercaptoethanol and 10 μg/mL polymyxin B sulfate (Sigma- Aldrich)) and added to round 
bottomed 96-well plates (Nunc, Naperville, IL, USA).   
 
4.3.4 JPP Labelling for High speed Cell Sorting of negatively selected B cells 
For negative sorting of B cells, 3 X 108 ovine JPP cells, at a final concentration of 1 X 108 
cells/mL PBS, were labelled with 18 µg anti-ovine CD25, 18 µg anti-ovine CD11c, 9 µg anti-
ovine CD14, 18 µg anti-ovine CD2, 18 µg anti-ovine CD4, 18 µg anti-ovine WC1-N2, 18 µg 
anti-ovine CD8, 18 µg anti-ovine SWC3 and 15 µg anti-ovine CD16.  JPP cells were 
incubated with mAbs for 20 min at 4 °C, with gentle mixing every 5 min. Cells were then 
pelleted by centrifuging at 311 x g for 8 min at 4 °C and washed twice with ice-cold PBS. 
The cell pellet was re-suspended in 3 mL PBS and the following fluorochrome-conjugated 
secondary antibodies were added: 20 µg goat anti-mouse IgG2a-PE; 20 µg of goat anti-mouse 
IgG1-PE; and 9 µg goat anti-mouse IgM- allophycocyanin. Cells were incubated in the dark 
at 4 °C for 15 min and then washed twice with ice-cold PBS.  
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Table 3. Monoclonal antibodies, isotype controls, and fluorochrome-conjugated secondary 
antibodies used to detect ovine leukocyte antigens. 
 
Bovine  
Leukocyte  
Antigen1 
 
Isotype 
 
Clone 
 
 Supplier 
 
TcR1 
CD25  
CD11c     
CD14     
CD2 
WC1-N2  
CD4 
CD8 
CD172a 
CD21 
CD72 
IgM 
IgA 
IgG1 
Control 
Control 
Control 
Control 
Control 
Control 
IgG1 
IgG2a 
IgM 
IgG1 
IgG2a 
IgG1 
IgG1 
IgG1 
IgG2b 
IgG1 
IgM 
IgG1 
IgG1 
IgM 
Mouse IgG1 
Mouse IgG2b 
Mouse IgM 
IgM/ Allophycocyanin 
IgG2b/FITC 
IgG1/PE 
86D 
CACT108A 
BAQ153A 
M-M9 
MUC2A 
BAQ4A 
17D 
CACT80C 
74-22-15A 
MCA1424G 
 
 
 
 
MG100 
MG2B00 
MGM00 
 
 
 
VMRD 
VMRD 
VMRD 
VMRD 
VMRD 
VMRD 
VMRD 
VMRD 
VMRD 
AbD Serotec 
VIDO 
VMRD 
VMRD 
VMRD 
Invitrogen 
Invitrogen 
Invitrogen 
BD Biosciences 
Invitrogend 
Invitrogen 
 
aVMRD (Pullman, WA); bAbD Serotec (Raleigh, NC); cBD Pharmigen (Mississauga, ON); 
dInvitrogen (Burlington, ON) 
 
4.3.5 High-speed Cell Sorting  
Labelled JPP cells were adjusted to a final concentration of 1x108 cells/mL in ice-cold PBS, 
filtered through 35 µm cell strainer capped 12x75 mm polystyrene round bottom tubes (Cat. 
No. 352235) (BD Falcon ON, CA) to remove cell clumps. High-speed sorting was performed 
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with a MoFlo XDP (Beckman Coulter Inc. CA, USA) equipped with a 488 argon and 633 
HeNe laser. FITC, PE and Allophycocyanin fluorescence was collected through 529/25, 
575/25 and 670/30 band-pass filters, respectively. Dot scatter plots of forward light scatter 
(FSC) and 90o light scatter (SSC) were displayed on a linear scale and used to define the first 
sort region (R1) which excluded dead cells and debris. Dot plots displaying FSC-Height/FSC-
Width were used to define the second sort region (R2) to exclude doublets or larger cell 
clumps. To negatively sort for B cells, a sort region was set to include all PP B cells and 
exclude Lin+ cells (R4). Sort conditions included a sheath pressure of 60 psi, a 70 µm nozzle, 
0.3 psi differential pressure, and a sort rate of 18-22,000 events/s. Sorted cells were collected 
in sterile 12x75 mm polypropylene round bottom tubes (VWR international, Mississauga, 
ON, CA) pre-coated overnight with 4% bovine serum albumen (BSA, Sigma, Ontario CA). 
Collection tubes were kept on ice throughout the sort and cells were transferred every 30 min 
to ice-cold AIMV medium (Invitrogen, Burlington, ON) supplemented with plus 10% fetal 
bovine serum (FBS, Invitrogen, Burlington, ON). 
 
4.3.6 Tissue culture conditions and stimulation with TLR agonists 
High-speed sorted cells were re-suspended in AIM V media. Aliquots of 5x105 cells for 
CD21+ and 3×105 for CD21- cells were cultured in triplicate wells in a final volume of 200 
μL. Cells were stimulated with TLR9 agonists B-class CpG 2007 or GpC 2007 as a control 
at 5 μg/mL and then incubated at 37°C in a 5% CO2 atmosphere and 95% humidity. For 
optimal detection of cytokines, cells were stimulated for 48 hours as previously described 
[141]. Culture supernatants were stored at -20oC until cytokines assays were performed. 
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4.3.7 Enzyme-linked immunosorbent assay (ELISA) for IgM, IL-10, IL-12 and IFN-γ   
ELISAs for quantifying IgM and cytokines in culture supernatants were performed 
according to previously described procedures as follows; IgM [2], IFN-γ [159], IL-12 [160] 
and IL-10  [140], with minor modifications. U/ml (units per ml) for IL-10 was defined 
previously by Kwong et al [140], as the biological activity of IL-10 with one unit being the 
reciprocal of the IL-10 dilution that inhibited IFN-γ secretion by 50 % of Cos-7 cells. 
 
4.3.8 Flow cytometry 
JPP cells were re-suspended at a final concentration of 20 x 106 cells/ml in PBSA containing 
0.03% sodium azide (EMD Chemicals). 50 μl aliquot of cells was added to each well of a 
U-bottom 96-well plate (Corning Inc. Life Sciences, Lowell, MA) and 5 µl aliquot of 
primary monoclonal antibody (mAb) for CD21, CD72, IgM, IgA, IgG1 (Table 3) were each 
added at a final concentration between 1-5 μg/ml. For each mAb the concentration was 
titrated to provide maximum labeling intensity without detectable background staining. 
Cells were incubated on ice for 20 minutes and then washed 3x by adding 200 μl 
PBSA/0.03% sodium azide. Fluorochrome-conjugated goat anti-mouse immunoglobulin 
(Ig) isotype-specific secondary antibodies (Life Sciences) were then added at a final 
concentration of 1 μg/ml and cells were incubated in the dark for 20 minutes on ice. Cells 
were then washed 3x with 200 μl PBSA/0.03% sodium azide before fixation with 200 μl 
2% formaldehyde (Sigma-Aldrich). Cells were stored at 4°C in the dark until analyzed with 
a FACS Calibur (Becton-Dickinson, Franklin Lakes, NJ) using Cell Quest acquisition and 
analysis software (Version 3.3). A minimum of 10,000 events were captured for each 
sample with data collected in list-mode.  
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4.3.9 Cytospins 
Negatively selected B cells were purified by high-speed cell sorting and re-suspended in 
PBSA containing 0.1% EDTA at a final concentration of 106 cells/ml. Glass slides 
(Superfrost Plus, VWR) were pre-coated in the cytospin (Cytospin 4, Fisher Scientific, 
Waltham, MA) with 25μlFBS by centrifuging slides at 300 RPM for 3 minutes. A 100 μl 
aliquot of cell suspension was then added to the cytospin funnel and centrifuged at 300 
RPM for 3 minutes. Slides were air dried overnight and then stained with Hemacolor 
staining kit (EMD Chemicals). Slides were again air-dried overnight before mounting cover 
slips with Cytoseal 60 (Richard-Allan Scientific, Kalamazoo, MI). 
 
4.3.10 Statistical analysis 
Data analysis was performed with the statistical software program, Graph Prism 5 (Graphpad 
software). Individual group differences were examined by performing one way analysis of 
variance (ANOVA). Values of P<0.05 were considered significant. Means of groups were 
reported and were compared using the Kruskal-Wallis test and Dunn’s test was used to 
perform the post-hoc tests. 
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4.4 Results 
4.4.1 B cells in Peyer’s patches are the only source of IL-10 
 Previous investigations in our laboratory have shown that an IL-10 secreting 
regulatory B cell (Bregs) are present in jejunal PP of lambs [1].  However, in these previous 
studies, B cells were enriched using MACS yielding about 95% purity. This raises the 
question as to whether only CD21+ B cells produce IL-10 in the PP or whether contaminating 
cells in the remaining 5% were directly or indirectly involved in IL-10 secretion. To address 
this issue, JPP cells were fractionated using high-speed cell sorting to negatively select B 
cells (Fig 5). 
 
 
Figure 5. Negative selection of B cells that are negative for other leukocyte lineage markers. 
 
Regions for high-speed sorting of negatively selected B cells populations, DCs and other cells 
(Monocytes, Macrophages, neutrophils, T cells) were first set to exclude cell debris (a) and 
doublets (b). The B cell sort region (R3) was defined based on the B cells being negative for 
CD25, CD4, CD8 (T cells), WC-1-N2 (γδT Lymphocytes) CD14 (monocytes), CD172a 
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(monocytes, granulocytes, dendritic cells and hematopoietic progenitor cells) and CD2 (NK 
cells) (c). Dendritic cells in R5 region were sorted on the basis of their CD11c expression. 
The rest of the cells were sorted in the R4 region. Cells within R4 were subsequently sorted 
into two subpopulations based on CD21 expression into CD21- (R8) or CD21+ cells (R9). 
Flow cytometry analysis of Lin- sorted cell populations’ revealed 99% purity for CD72 (d), 
and 99% purity for other cells (e).This procedure yielded B cell purity of 99% (Fig 6).  
 
 
 
 
 
 
 
                                                      CD72 
Figure 6. Flow cytometry figures showing sorted B cells purity. 
Sorted JPP B cells were stained as described in section 4.3.8 of this thesis. The cells were 
then analyzed with a FACS Calibur (Becton-Dickinson, Franklin Lakes, NJ) using Cell 
Quest acquisition and analysis software (Version 3.3). A minimum of 10,000 events were 
captured for each sample with data collected in list-mode 
 
IL-10 production was then assayed in culture supernatants from the individual sorted 
JPP cell populations. Unfractionated JPP cells spontaneously secreted IL-10. Stimulation of 
unfractionated JPP cells with CpG or control GpC ODN did not result in a significant increase 
99.15% 0.85% 
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in IL-10 production relative to the medium (Fig 7a). We then assessed IL-10 production in 
high-speed sorted B cells (JPP B cells).  JPP B cells cultured in medium, spontaneously 
secreted IL-10 and CpG or GpC stimulation did not result in significant increase in B cell 
production of IL-10 (Fig 7b). Furthermore, the level of IL-10 secretion by purified JPP B 
cells was similar to unfractionated JPP cells. 
 
In PP, the CD21 marker is expressed on B cells as well as follicular dendritic cells 
[150]. We therefore sought to determine whether PP DCs might also be a source of IL-10 
secretion. No IL-10 was detected in the culture supernatant of sorted CD11c+ (Dendritic cells) 
cells regardless of whether they were stimulated with CpG or GpC (Fig 7c). Therefore, PP 
CD11c+ cells did not secrete detectable levels of IL-10. 
 
 Previous work in cattle suggested an interaction between B cells and myeloid cells 
was required for optimal CpG ODN activation of B cells [161, 162]. We therefore 
investigated whether an interaction between B cells and DCs might enhance IL-10 secretion 
by B cells. JPP B cells were co-cultured with DCs (B cells + CD11c+). Unstimulated JPP B 
cells + CD11c+ cells secreted IL-10, and the levels were similar to those observed in purified 
JPP B cells. Further stimulation of JPP B cells + CD11c+ cells with either CpG or non GpC 
ODN did not result in significantly increased IL-10 production (Fig 7d). These observations 
confirm that CD11c+ cells (DC) do not contribute to the IL-10 production by JPP B cells. 
There was also no IL-10 secretion in the CD21- cell population regardless of stimulation with 
CpG or GpC ODN (Fig 7e). These results support the conclusion that B cells are the only 
source of IL-10 in cultured sheep PP cells. 
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 Figure 7.  IL-10 production in sorted PP cells. U
nfractionated JPP (a), highly purified unfractionated JPP B cells (b), CD
11c 
(D
C) (c), B + CD
11c (d) and JPP other cells (e), w
ere cultured for 48 hours in m
edium
 alone, or in the presence of 5 µg/m
l 
of CpG
 or G
pC O
D
N
. IL-10 production w
as evaluated in the culture supernatants by IL-10 ELISA
. D
ata for individual 
anim
als are presented w
ith m
ean value indicated by horizontal bar for each group (n=5).  
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4.4.2 CD72+CD21+ B cells but not CD72+CD21- B cells secrete IL-10 
 All sheep B cells express the CD72 marker except plasma cells, but only a subset of 
B cells express CD21 [163, 164].  It is not clear whether CD21- B cells also secrete IL-10. 
To determine whether CD21- B cells secrete IL-10, PP B cells were fractionated into 
CD72+CD21+ and CD72+CD21- cell populations. These cells were then stimulated with 
CpG and GpC ODN, and IL-10, IL-12, IFN-γ and IgM concentrations were assayed in the 
supernatants.  
 
 Unfractionated JPP cells and CD72+CD21+ cell populations spontaneously secreted 
significantly higher levels of IL-10 compared to the CD72+CD21- cell population (Fig 8a). 
Stimulation of unfractionated JPP and CD72+CD21+ cell populations with CpG or GpC did 
not result in a significant increase in IL-10 production (Fig 8a). Unstimulated and stimulated 
CD72+CD21- and CD72-CD21- cell populations did not secrete any IL-10 (Fig 8a). This 
observation supports the conclusion that only CD21+ PP B cells produce IL-10, and 
regulatory B cells are present in this population.  
 
4.4.3 CD72+CD21- B cells, but not CD72+CD21+ B cells secrete IL-12 
Effector B cells are characterized by the secretion of  a variety of cytokines 
including  IL-12 [165]. Therefore, we evaluated the production of IL-12 by CD72+CD21+ 
and CD72+CD21- B cells populations.  
 
Low levels of IL-12 were spontaneously secreted by unfractionated JPP cells (Fig. 
8b). There was significantly increased IL-12 production by the unfractionated JPP cell 
population following CpG ODN stimulation.  
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CD72+CD21+ B cells population did not spontaneously secrete a detectable level 
of IL-12 and stimulation with CpG or GpC ODN did not induce IL-12 secretion (Fig 8b).  
This is consistent with previous observations [1]. In contrast, CD72+CD21- B cells 
secreted IL-12 following stimulation with CpG ODN (Fig 8b). Therefore CD21+ B cells 
were not a source of detectable IL-12 production, but B cells in the CD72+CD21- 
population produce this cytokine in response to CpG ODN. 
 
4.4.4 IFN-γ is secreted by CD72+CD21- B cells, but not CD72+CD21+in PP 
Effector B cells are also characterized by the secretion of  a variety of cytokines 
including IFN-γ  [165]. There was no detectable IFN-γ secretion by either unstimulated or 
CpG ODN stimulated unfractionated JPP cells (Fig.8c). Very low levels of IFN-γ were 
detected in the culture sup of unstimulated CD72+CD21- B cells and significantly 
increased IFN-γ levels were detected following CpG ODN stimulation. Similarly, 
unstimulated CD72-CD21- cells produced very low levels of IFN-γ, but stimulation of 
these cells with CpG or GpC ODN resulted in no detectable increase in IFN-γ production. 
These observations support the conclusion that in PP, a major source of IFN-γ is the 
CD72+CD21- B cell population, but TLR agonist stimulation is required (Fig 8c). 
 
4.4.5 CD72+CD21- B cells, but not CD72+CD21+ B cells secrete IgM in the PP 
 Regulatory B cells in sheep PP do not to secrete IgM [1]. Therefore, we investigated 
whether there was an effector B cell sub-population in the PP that could secrete IgM. 
Purified JPP CD72+CD21- B cells and CD72+CD21+B cells were cultured for 48 hours and 
supernatants were assayed for IgM secretion. 
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 Unfractionated JPP cells spontaneously secreted IgM (Fig. 8d) and stimulation of 
these cells with CpG or GpC did not result in significantly increased IgM production. 
C72+CD21+ B cells did not spontaneously secrete IgM and CpG or GpC stimulation had no 
effect on antibody production.  In contrast, C72+CD21- B cells spontaneously secreted IgM 
at levels similar to the unfractionated JPP population. Stimulation of the C72+CD21- cell 
population with CpG or GpC did not induce a significant increase in IgM secretion (Fig 8d). 
 
There was however no IgM production in the CD72-CD21- population (The rest of 
the cells that include T cells, macrophages and DCs). These observations suggest that 
C72+CD21- cells (effector B cells), capable of secreting IgM are present in the PP. 
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Figure 8.  IL-10 (a), IL-12 (b), IFN-γ (c) and IgM (d) production in unfractionated and 
sorted PP subpopulations. Unfractionated JPP, highly purified JPP CD72+CD21+ B cells, 
JPP CD72+CD21- B cells and JPP CD72-CD21- cells were cultured for 48 hours in medium 
alone, or in the presence of 5 µg/ml of CpG or GpC ODN. IL-10, IL-12, IFN-γ and IgM 
production was evaluated in the culture supernatants by IL-10, IL-12, IFN-γ and IgM 
ELISA. Data for individual animals are presented with the mean value indicated by 
horizontal bar for each group (n=5). JPP; jejunal Peyer’s patch cells. 
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4.4.6 IL-10 secreting CD21+ B cells are sIgM+, sIgA+and sIgG1+ 
 Having confirmed that CD21+ B cells were the sole source of spontaneous IL-10 in 
PP, we then investigate whether B cells which had undergone isotype switching could still 
produce IL-10. Therefore, the negatively sorted B cell population was further fractionated 
based on surface immunoglobulins expression (sIgM+, sIgA+ or sIgG1+ populations) (Fig 
9).  
 
Figure 9. Sorting of B cells based on surface Ig expression. 
 
Regions for high-speed sorting of negatively selected B cells populations were first set to 
exclude cell debris (a) and doublets (b). B cells were first negatively sorted based on the B 
cells being negative for CD25, CD4, CD8 (T cells), WC-1-N2 (gamma-delta T Lymphocytes) 
CD14 (monocytes), CD172a (monocytes, granulocytes, dendritic cells and hematopoietic 
progenitor cells) and CD2 (NK cells) (Fig 5). Cells were there after sorted into three 
subpopulations based on expression of IgM (R3), IgA (R4) and IgG1 (R5) (c). Flow 
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cytometry analysis of sorted cell populations revealed 96% purity for IgG1 (d), 98% purity 
for IgM (e) and 97% for IgA (f).  
 
Figure 10. Phenotype analysis of negatively sorted JPP B cells  
 
Sorted JPP B cells were stained as described in section 4.3.8 of this thesis. The cells were 
then analyzed with a FACS Calibur (Becton-Dickinson, Franklin Lakes, NJ) using Cell 
Quest acquisition and analysis software (Version 3.3). A minimum of 10,000 events were 
captured for each sample with data collected in list-mode. Negatively sorted B cells were 
99.8% CD72+ (b), 51.5% sIgG1+ (c), 44.4% sIgA+ (d) and 2.0% sIgM+ (e) (Fig 10a). 
Cytospins were also performed to ascertain the phenotypes of the sorted B cells (Fig. 11). 
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The sIgM+, sIgA+ and sIgG1+ B cells all spontaneously secreted similar levels of IL-10 (Fig 
12). The fractionated negatively selected B cell population was included a positive control.  
The levels of spontaneous IL-10 secreted by the unstimulated sIgM+, sIgA+ and sIgG1+ B 
cells were not significantly different from the levels produced by the unstimulated 
unfractionated JPP B cells (Fig 12). 
Figure 12.  IL-10 production in sorted sIg+ PP B cells. Highly purified JPP B cells, sIgM+ B 
cells, sIgA+ B cells and sIgG1+ B cells were cultured for 48 hours in medium alone, or in the 
presence of 5 µg/ml of CpG or GpC ODN. IL-10 production was evaluated in the culture 
supernatants by IL-10 ELISA. Data for individual animals are presented with mean value 
indicated by horizontal bar for each group (n=5).  
Figure 11. Cytospin of negatively sorted PP B cells  
 
* Cytospin for sorted B cells revealed B cells in 2 sizes. 
Large and small. Scale bar = 10 µm; magnification = 
100X. 
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4.5 Discussion 
In the present investigation, we provide evidence for the existence of two B cell sub-
populations present in JPP of sheep; (i) a regulatory B cell (CD72+CD21+) and (ii) an 
effector B cell (CD72+CD21-) population. The regulatory B cells secreted IL-10 and the 
effector B cells secreted IL-12, IFN-γ and IgM. This is consistent with a model proposed by 
Mizoguchi and Ban [3]. Furthermore, we confirmed that regulatory CD21+ B cells were the 
only source of detectable IL-10 secretion by ovine PP B cells. 
 
Regulatory B cells are now recognized as an important component of the immune 
system and are characterised by IL-10 secretion [3]. They were first reported by Janeway and 
colleagues [125] who provided evidence for a direct regulatory role of B cells in  
experimentally induced autoimmune encephalomyelitis (EAE) [125, 126]. Further evidence 
of Bregs have been shown in other disease models [3]. The mechanisms that regulate Breg 
development and function are not yet clear, but various molecules, including TLR ligands, 
CD154 (CD40L), foreign antigens, and IL-21, were shown to promote differentiation of B 
cells to Bregs by signalling through cognate receptors on B cells [127, 166, 167]. Accumulating 
evidence suggests that the Bregs cell population is heterogeneous. Thus, this population can be 
derived from all B cells when presented with the correct stimulatory context and appropriate 
duration of stimulus [168].  
 
 It is thought that IL-10 is the primary mediator in the immune regulation mediated 
by Bregs [1]. IL-10 mediates suppression of inflammation by several mechanisms, including 
down regulation of the production of pro-inflammatory cytokines, such as IL-6, IL-12, IL-
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17, IL-18, IFN-γ, TNF-α and the expression of MHC class II [143-145]. We have previously 
reported that CD21+ B cells produce IL-10 [1, 76]. However, the B cells used in these earlier 
studies were obtained by MACS enrichment and had a purity of 95%. It was possible that 
contaminating cells, such as FDCs, may have contributed, to the IL-10 production. To address 
this issue, we negatively sorted B to increase B cell purity to 99%. Using these negatively 
sorted B cells we have now confirmed that only CD21+ PP B cells secrete IL-10. All the other 
cells evaluated in the PP including DCs, T cells, monocytes and macrophages did not 
spontaneously secrete detectable levels IL-10. Thus, using highly purified CD21+ B cells, we 
have confirmed that Bregs within the CD21+ B cell population are the only source of 
spontaneously secreted IL-10 when cell were isolated from sheep PP. Furthermore, these 
CD21+ Bregs do not secrete detectable levels of IL-12, IFN-γ, or IgM with or without CpG 
ODN stimulation. 
 
Effector B cells are positive regulators of immune response and can be divided into 
two subfamilies on the basis of cytokine secretion. B effector 1(Be1) cells are characterised 
by a Th1-like cytokine secretion pattern and B effector2 (Be2) cells are characterised by a 
Th2-like cytokine secretion pattern [9, 136]. Effector B cells terminally differentiate into 
plasma cells that have undergone Ig isotype switching and secrete antibodies [138]. In the 
present investigation, we provide evidence for the existence of an effector B cell population 
(CD72+CD21-) in the PP which produces IL-12, IFN-γ, and IgM. However, further studies 
are required to determine whether they can be further subdivided into Be1 or Be2 cells. 
Other cells known to express CD72 including follicular dendritic cells, NK cells, splenic red 
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pulp macrophages (but not on peripheral blood monocytes), and liver Kupffer cells [109, 
169]. 
 
Interestingly, we found that CD72+CD21- effector B cells produce IFN-γ upon 
stimulation with CpG ODN. IFNs are known for their antiviral activity and ability to 
regulate the functions of cells of innate and adaptive immunity. IFN-γ is a potent activator 
of the antimicrobial functions of phagocytes, and has an essential role in resistance to many 
pathogenic bacteria, fungi and intracellular parasites. It is produced primarily by natural 
killer (NK) cells and by the bystander activation of particular subsets of T cells, for 
example, NKT cells, CD8+ T cells, CD4+ T cells and γδ T cells, by dendritic cells (DCs) 
and B cells [170, 171]. B cells with innate immune functions that produce IFN-γ in huge 
amounts have recently been discovered [172]. These effector B cells produce IFN-γ in 
response to challenge with Listeria monocytogenes, Escherichia coli, vesicular stomatitis 
virus and Toll-like receptor ligands. They promote innate responses against intracellular 
bacterial infection by secreting IFN-γ through a feedback mechanism [172]. The 
difference between these effector B cells and our effector B cells is that the effector B cells, 
as described by others, are seen during infection or in disease conditions whereas our 
investigations reveal that JPP effector B cells exist in healthy animals.  
 
B cells from sheep produce IgM in response to CpG stimulation [2]. It was 
previously reported that the CD21- population can secrete IgM [2]. We have now confirmed 
that the CD21- population includes B cells that are CD72+CD21- and CD72-CD21. This is 
consistent with the presence of an effector B cell population in the PP. We were unable to 
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further fractionate these cells further into the CD72-CD21- population due to very low cell 
numbers. 
 
Also of interested was the finding that B cells that had undergone isotype switching 
secrete similar levels of IL-10. It may be that some B cells need to undergo isotype 
switching to acquire the capacity to secrete IL-10. Alternatively, Breg function may present 
following isotype switching. The isotype switched Bregs may be similar to the recently 
discovered inducible Bregs detected in the blood of sheep infected with bovine leukaemia 
virus that secrete IL-10 spontaneously and can be induced by CpG ODN to secrete IL-10 
(unpublished observation).  
 
 The significance of the presence of effector and regulatory B cells in the PP is that 
they may ensure that effector immune responses generated in intestines can be appropriately 
regulated to avoid chronic inflammation and pathology. Further investigations are required 
to provide insight into how these functions are integrated in PP. In conclusion, this study 
confirms that only CD21+ PP B cells spontaneously secrete IL-10. We therefore conclude 
that Bregs are present in this population. Furthermore, we demonstrated that both effector 
and regulatory B cell populations co-exists in the PP and that isotype-switched B cells may 
also include Bregs. 
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CHAPTER 5: DISTRIBUTION OF IL-10 SECRETING CD21+ Bregs IN OVINE 
LYMPHOID TISSUES AND THE EXISTENCE OF Bregs IN NEONATAL CALVES 
 
Relationship of this study to the dissertation. 
 
In Chapter 4, we confirmed that only CD21+ PP B cells spontaneously secrete IL-10. 
We also demonstrated that both effector and regulatory B cell populations co-exists in the PP 
and that isotype-switched B cells may also include Bregs. We therefore wondered whether 
ovine Bregs exist in other lymphoid tissues besides PP and whether they are present following 
isotype switching. We also hypothesized that Bregs are present in cattle and are not unique to 
sheep. Our investigations in this chapter provides evidence that Bregs exist at varying 
frequencies in both mucosal and systemic tissues. In addition, we confirmed the presence of 
CD21+ Bregs in bovine JPP. 
 
5.1 Abstract 
We have confirmed that IL-10 secreting CD21+ regulatory B cells (Bregs) can be isolated 
from jejunal Peyer’s patches (PP) and this IL-10 production suppresses secretion of IL-12 
and IFN-γ. However, it is not known whether these Bregs are restricted to JPP or also present 
in other lymphoid tissues. It is also not known whether Bregs are present in other ruminant 
species. Therefore, CD21+ B cells were purified from the jejunal PP of sheep and cattle as 
well, and from ovine mesenteric lymph nodes (MLN), tonsils, bronchial lymph nodes (BLN), 
PBMC, and spleen using magnetic cell sorting.  Purified CD21+ B cells were then stimulated 
with the TLR9-agonist, CpG ODN (CpG oligodeoxynucleotide). The frequency of IL-10-
secreting cells in each tissue was evaluated by ELISPOT. We detected IL-10 secreting cells 
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in CD21+ B cells in both mucosal (jejunal PP, bronchial, MLN and tonsils) and systemic 
(spleen and blood) lymphoid tissues, and the frequency of CD21+ B cells secreting IL-10 was 
not changed by CpG ODN stimulation. Mucosal lymphoid tissues (Bronchial and mesenteric 
LNs and JPP) had high numbers of IL-10 secreting B cells, with JPP having the highest 
numbers of IL-10 secreting cells while tonsils had the least. The frequency of IL-10 secreting 
B cells was low in blood and spleen. Our investigations provide evidence that Bregs exist at 
varying frequencies in both mucosal and systemic tissues. In addition, we confirmed the 
presence of CD21+ Bregs in bovine JPP. 
 
Key words: Bregs; Bovine; CpG ODN; ELISPOT; MLN; regulatory cells; Peyer’s patches; 
sheep; TLR9  
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5.2 Introduction 
The idea that B cells could regulate immune responses originated in 1974, when the 
ability of B cells to suppress delayed-type hypersensitivity responses in guinea pigs was 
described [123, 173]. About two decades later, Janeway (1996) and colleagues were the first 
to provide direct evidence for a direct B cell regulatory role in a mouse model (μMT – a strain 
genetically deficient in B cells) of experimentally induced autoimmune encephalomyelitis 
(EAE) [125, 126]. Mizoguchi and colleagues later coined the term regulatory B cells (Bregs) 
to designate B cells with regulatory properties independent of secreted immunoglobulins 
[122] [3]. Bregs exert their regulatory activities through IL-10 production. Regulatory B cells 
have thus become a focus of increased investigations in recent years, but currently all these 
studies have used mice.  
 
 Ovine sIgM+ CD21+ B cells are representative of naive B cells, are localized in the 
B cell follicles of spleen, LNs and PP’s, and are actively re-circulating [107, 108]. We 
recently reported that ovine CD21+ B cells isolated from jejunal PP’s produced IL-10 with a 
regulatory function and these Bregs were present in the fetus prior to antigen exposure [1, 
76]. However, it is not known whether ovine Bregs exist in other lymphoid tissues besides PP 
and whether they are present following isotype switching. It is also not known whether Bregs 
are present in other ruminant species or are unique to sheep. CD21+ B cells are also present 
in PP of cattle, so we investigated whether Bregs may also be present in cattle.  
 
 
 
71 
 
5.3. Materials and methods 
5.3.1  Animals 
Suffolk sheep of either sex, between 3-4 months old, and male calves of either sex, 
between 1-2 weeks of age were obtained from the Department of Animal and Poultry Science 
(University of Saskatchewan, Saskatoon, SK, Canada). Experiments were conducted in 
accordance with the Guide to the Care and Use of Experimental Animals, provided by the 
Canadian Council on Animal Care. All experimental protocols were approved by the 
University of Saskatchewan Animal Care Committee.  
 
5.3.2 CpG Oligodeoxynucleotides 
The CpG ODN 2007 and CpG ODN 2007 GC were obtained from Merial limited 
(Lyon, France). There sequences and backbone structures; were previously discussed [76].  
 
5.3.3 Enzyme-linked immunosorbent SPOT assay (ELISPOT) for IL-10 
Jejunal Peyer’s patches, bronchial lymph nodes (BLN), mesenteric lymph nodes 
(MLN), tonsils, spleen and PBMC were isolated from the respective tissues and CD21+ and 
CD21- cell populations were fractionated from these populations using magnetic cell sorting. 
The frequency of IL-10-producing cells within unfractionated, CD21+ and CD21- JPP, BLN, 
MLN, tonsils, spleen and PBMC cells was determined by ELISPOT. Flat-bottom, 
polyvinylidene difluoride-coated, 96-well plates (Millipore, Bedford, MA, USA) were pre-
wet with 100 µL 70% ethanol/well (Sigma Chemical Co.), washed with PBS, and coated 
overnight at 4°C or for 1 h at 37°C with mouse anti-recombinant bovine IL-10 CC318 
(Serotec MCA 2110) diluted to 1.0 μg/mL in coating buffer. Plates were then washed four 
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times with Tris buffered saline /0.05% Tween 20 (Sigma-Aldrich) (TBST) then 5x105 cells 
were seeded in 100 µl AIMV medium per well in triplicate wells. Plates were incubated at 
37°C, 5% CO2, for 24 h, washed 4 times with PBS, and incubated for 2 h with 0.125 μg/well 
biotinylated mouse anti-bovine IL-10 antibody (Serotec MCA 2111B). Plates were washed, 
and 100 μL of streptavidin-alkaline phosphatase (Mabtech, 1:1000 dilution) was added for 1 
h. After washing, 100 μL freshly prepared NBT chloride (3 mg/mL) / 5-bromo-4-chloro-3-
indolyl phosphate-p-toluidine (1.5 mg/mL) substrate (BioRad, Hercules, CA, USA) in Tris 
buffer (pH 9.5) was added to each well for 20 min. Plates were washed with distilled water 
to stop the reaction and air-dried overnight before spot enumeration. The number of IL-10-
producing cells per million cells from each tissue were determined by multiplying the number 
of spots / well by 2 and then averaging values from triplicate wells. U/ml (units per ml) for 
IL-10 was defined previously by Kwong et al [140], as the biological activity of IL-10 with 
one unit being the reciprocal of the IL-10 dilution that inhibited IFN-γ secretion by 50 % of 
Cos-7 cells. 
 
5.3.4 Lymphocyte Proliferative responses 
Bovine lymphocyte proliferative responses were assayed according to previously 
described procedures described  [76]. 
 
5.3.5 Isolation of Jejunal Peyer’s patches, bronchial lymph nodes (BLN), mesenteric 
lymph nodes (MLN), tonsils, spleen and PBMC cells 
Lambs were euthanised and JPP, BLN, MLN, tonsils, spleen tissues immediately 
removed and placed in ice-cold DMEM (GibcoBRL) containing antibiotics (100 U/mL), 
Penicillin, 100 μg/mL Streptomycin sulfate, 0.25 μg/mL Amphotericin B (Sigma-Aldrich).  
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PBMC were isolated as previously described [1]. Single cell suspensions were isolated from 
JPP, BLN, MLN, tonsils, spleen and blood as described previously [141]. The number of 
viable cells isolated from all tissues was determined by trypan blue dye exclusion and viable 
cells were counted with a hemocytometer under a light microscope. Cells were re-suspended 
at the appropriate concentrations in AIM V medium, (supplemented with 2% FBS, 100U/mL 
penicillin, 100 μg/mL streptomycin sulfate, 0.25 μg/mL amphotericin B, 2Mm L-glutamine, 
50 μM 2-mercaptoethanol and 10 μg/mL polymyxin B sulfate (Sigma- Aldrich) and added in 
100 µ/well in round bottomed 96-well plates (Nunc, Naperville, IL, USA).   
 
5.3.6 Magnetic activated cell sorting (MACS) 
JPP, BLN, MLN, tonsil and spleen cells suspensions and PBMC were stained with 
mouse anti-bovine CD21 (IgG1 isotype; AbD Serotec, UK) for 15 min at 40C. The JPP, BLN, 
MLN, tonsils, spleen and PBMC cells were then washed twice with MACS buffer (PBSA, 
0.5M EDTA, 10% BSA). Cells were pelleted by centrifugation for 8 min at 440 x g. The JPP, 
BLN, MLN, tonsil and spleen cells suspensions and PBMC were then stained with goat anti-
mouse IgG1 phycoerythrin (PE) conjugate (ABD Serotec, UK) for 15 min at 40C before 
washing as above. The JPP, BLN, MLN, tonsils, spleen and PBMC cells were then incubated 
with anti-PE magnetic beads for 15 min at 40C and passed through the LC MACS column 
(Miltenyi Biotec, Bergish Gladbach, Germany) according to manufacturer’s instruction. The 
CD21+ B cell fraction was eluted, washed in PBSA and re-suspended in AIM V media 
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5.3.7 Tissue culture conditions and stimulation with TLR agonists 
Isolated CD21+ cells were re-suspended in AIM V media. Aliquots of 5x105 cells for 
unfractionated JPP, BLN, MLN, tonsils, spleen and PBMC cells, 5x105 for CD21+ cells and 
3x105 cells for CD21- cells were cultured in triplicate wells in a final volume of 200 μL. Cells 
were stimulated with B-class CpG 2007 or GpC 2007 at 5 μg/mL and then incubated at 37°C 
for 48 hours in a 5% CO2 atmosphere and 95% humidity. For optimal detection of cytokines, 
cells were stimulated for 48 hrs as previously described [141]. Culture supernatants were 
stored at -20oC until assayed for secreted cytokines. 
 
5.3.8 Enzyme-linked immunosorbent assay (ELISA) for IFN-γ, IFN-α, IL-12 and IL-10 
The IFN-γ, IFN-α, IL-12 and IL-10 enzyme-linked immunosorbent assays used in these 
studies were shown previously to detect ovine and bovine IFN-γ, IFN-α, IL-12 and IL-10 
cytokines as described elsewhere [141, 160, 174]. 
 
5.3.9 Statistical analysis 
Data analysis was performed with the statistical software program, Graph Prism 5 
(Graphpad software). Data that were not normally distributed were transformed by ranking. 
Individual group differences were examined by performing one way analysis of variance 
(ANOVA). Values of p<0.05 and p<0.01, were considered significant and very significant 
respectively. Kruskal-Wallis test and Dunn’s test was used to perform the post-hoc tests. 
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5.4. RESULTS 
We have previously shown that IL-10 secreting CD21+ Bregs exist in jejunal PPs of 
lambs of different ages [76]. However, it is not known whether these Bregs are also present in 
other lymphoid tissues. We therefore performed experiments to determine the frequency of 
Bregs in the spleen, mesenteric lymph node (MLN) PBMC, tonsils and bronchial lymph nodes 
(BLN) and compared to JPP. 
5.4.1 Frequency of IL-10 secreting cells in JPP 
The frequency per million cells of IL-10 secreting cells present in JPP of 3-4 month old 
lambs was determined with an ELISpot essay. There was on average 207 (90 - 372 cells per 
million) IL-10 secreting cells per million cells in the unfractionated JPP population. There 
was, however, no change in the frequency of IL-10 producing B cells following stimulation 
with CpG or non CpG ODN (Fig 13a). Similarly, enriched JPP CD21+ B cells had a similar 
frequency of IL-10 secreting cells (124 - 500 cells per million). The number of CD21+ B cells 
secreting IL-10 did not change significantly even after stimulation with CpG or non GpC 
ODN (Fig 13a). There were however, no or few (0 - <100 cells per million) IL-10 secreting 
cells in the unstimulated CD21- cell population and this did not change with CpG stimulation. 
These results are consistent with our previous observations in PP cells isolated from this age 
group of lambs [1, 76]. 
 
5.4.2 Frequency of IL-10 secreting cells in bronchial lymph nodes (BLN) 
There were on average 80 (6 -142 cells per million) IL-10 secreting cells per million 
cells in the unstimulated BLN cell unfractionated population. This frequency did not change 
following stimulation with CpG or GpC ODN (Fig 13b). Similarly, enriched unstimulated 
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BLN CD21+ B cells contained IL-10 secreting cells with an average frequency of 70 IL-10 
secreting cell per million somatic cells and this frequency did not change significantly 
following CpG or non-CpG ODN stimulation (Fig 13b). There were relatively (8 to <38 cells 
per million) fewer IL-10 secreting cells in the unstimulated CD21- cell population, and this 
frequency did not change with CpG or non-CpG ODN stimulation. These results confirm that 
CD21+ B cells spontaneously secreting IL-10 are present in BLN.  
 
5.4.3 Frequency of IL-10 secreting cells in Mesenteric Lymph Node (MLN)  
There were on average 37 (10 - 80 cells per million) IL-10 secreting cells per million 
unfractionated and unstimulated MLN cells. The frequency of spontaneous IL-10 secreting 
cells in the MLN cell population was not significantly increased following stimulation with 
CpG or non CpG ODN (Fig 13c). Enriched MLN CD21+ B cells had spontaneous IL-10 
secreting cells, with on average 32 IL-10 secreting cells per million cells and this did not 
significantly change following CpG or non CpG ODN stimulation (Fig 13c). There were very 
few IL-10 secreting cells in the CD21- cell population following CpG or non CpG stimulation. 
The average frequency of IL-10 secreting cells in the CD21- MLN cell population was 19 
cells per million leukocytes. 
 
5.4.4 Frequency of IL10 secreting cells in the Tonsils  
The IL-10 ELISpot analysis of IL-10 secreting cells in the tonsils revealed an average 
of 16 spontaneous IL-10 secreting cells per million leukocytes (8 – 22 cells per million) in 
the tonsils. The frequency of IL-10 secreting cells did not increase following stimulation with 
CpG or non CpG ODN (Fig 13d). Similarly, enriched CD21+ B cells had an average 
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frequency of 17 spontaneous IL-10 secreting cells per million leukocytes and IL-10 secreting 
cell frequency was not significantly increased following CpG or non CpG ODN stimulation 
(Fig 13d). In the CD21- population, no IL-10 secreting cells were detected either before or 
after CpG or non CpG stimulation (Fig 13d). 
Figure 13.  IL-10 secreting cells in JPP (a), BLN (b), MLN (c) and tonsils (d). Unfractionated, 
CD21+ B cells and CD21- JPP, BLN, MLN and tonsil cells were cultured for 48 hours in 
medium alone, or in the presence of 5 µg/ml of CpG or GpC ODN. The frequency of IL-10 
secreting cells was enumerated using ELISpot. Data for individual animals are presented with 
mean value indicated by horizontal bar for each group.  
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5.4.5 Frequency of IL-10 secreting cells in the systemic lymphoid tissues (spleen and 
blood) 
5.4.5.1 Frequency of IL-10 secreting cells in PBMC  
The frequency of spontaneous IL-10 secreting cells in the unfractionated PBMCs was 
low with on average 30 cells per million leukocytes (6 – 52 cells per million) and this 
frequency did not change significantly following stimulation with CpG ODN (Fig 14a). 
Enriched CD21+ PBMC had a similar low frequency of IL-10 secreting cells (50 IL-10 
secreting cells per million cells) and the frequency of IL-10 secreting cells did not increase 
significantly following CpG ODN stimulation (Fig 14a). The CD21- PBMC fraction had very 
few IL-10 secreting cells (0 to 62 cells per million) and this frequency, (15 cells per million) 
did not change significantly after stimulation with CpG or non CpG ODN. 
 
5.4.5.2  Frequency of IL-10 secreting cells in the spleen 
There were on average 51 spontaneous IL-10 secreting cells (0 – 180 cells per million) 
in unfractionated splenocytes. This frequency did not change significantly following 
stimulation with CpG or non CpG ODN (Fig 14b). Similarly, enriched CD21+ splenocytes 
spontaneously secreted IL-10 with an average of 130 IL-10 secreting cells per million (26 – 
280) and their frequency was not significantly changed following CpG or non CpG ODN 
stimulation (Fig 14b). There were, however, very few IL-10 secreting CD21- cells (0 – 11 
cells per million), with or without CpG or non CpG ODN stimulation. 
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 Figure 14.  IL-10 secreting cells in PBMC (a) and spleen (b). Unfractionated, CD21+ and 
CD21- PBMCs and splenocytes were cultured for 48 hours in medium alone, or in the 
presence of 5 µg/ml of CpG or GpC ODN. The frequency of IL-10 secreting cells was 
enumerated using ELISPOT. Data for individual animals are presented with mean value 
indicated by horizontal bar for each group (n=5). 
 
5.4.7 IL-10 production by neonatal bovine CD21+ B cells  
We previously reported that PP CD21+ B cells from sheep spontaneously secrete IL-
10 and we called these cells Bregs [76]. These cells dampen other pro-inflammatory responses 
in the PP [76]. We therefore performed experiments to determine whether Bregs were also 
present in the JPP of newborn (1-8 days old) calves.  
 
Unfractionated JPP cell population spontaneously secreted significant (P<0.05) levels 
of IL-10 when compared to the CD21- cell population. Stimulation of these cells with CpG 
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or GpC did not result in a significant change in the level of IL-10 secretion (Fig 15a). 
Similarly, unstimulated CD21+ B cells secreted IL-10 and stimulation with CpG or GpC did 
not alter in IL-10 secretion (Fig 15a). There was no detectable IL-10 secretion by the 
stimulated or unstimulated CD21- cell populations. These results confirm that bovine CD21+ 
B cells are the only source of IL-10 in JPP of bovine neonates and that these cells 
spontaneously secrete IL-10 spontaneously.  
 
5.4.8 IL-12 production by bovine neonatal JPP cells  
  Previous work in our laboratory has shown that Bregs from ovine PP from sheep 
spontaneously secreted IL-10 but not IL-12 or IFN-γ [1]. We therefore evaluated IL-12 
production by bovine CD21+ B cells.  
 
There was very low spontaneous IL-12 secretion by unfractionated JPP cells (Fig 
15b). Stimulation of JPP cells with CpG or non CpG ODN (GpC) did not significantly 
change IL-12 secretion. Furthermore, IL-12 secretion was not detected in unstimulated 
CD21+ B cells or following CpG or GpC ODN stimulation. These results are consistent 
with previous observations [76]. Interestingly, CD21- JPP cells spontaneously secreted IL-
12 and IL-12 secretion increased significantly following CpG ODN stimulation (Fig 15b). 
Thus, stimulation of JPP CD21+ does not induce IL-12 production, but CpG stimulated 
JPP CD21- secrete detectable levels of IL-12. 
 
5.4.9 IFN-γ production by bovine neonates PP B cells 
Low levels of spontaneous IFN-γ secretion were observed with unfractionated 
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cells (Fig 15c). There was however no significant change in IFN-γ levels following 
stimulation with CpG or GpC ODN. There was no detectable IFN-γ secretion in the 
CD21+ JPP B cell population following stimulation with CpG or GpC ODN which was 
consistent with our earlier observation [76]. There was however, a low level of 
spontaneous IFN-γ secretion by the CD21- JPP cells and stimulation with CpG or GpC 
ODN significantly increased IFN-γ production (Fig 15c). CD21- JPP cells were the only 
source of IFN-γ in the bovine JPP. Therefore, bovine PP CD21+ did not secrete IFN-γ, but 
PP CD21- cells did secrete this cytokine following CpG ODN stimulation. 
 
5.4.10 IFN-α production by neonatal bovine PP B cells 
Low levels of IFN-α were spontaneously secreted by unfractionated JPP cells (Fig 
15d) and there was no significant change in IFN-α secretion following stimulation with 
CpG or GpC ODN. Interestingly, there was no detectable spontaneous IFN-α secretion by 
CD21+ JPP B cells. Furthermore no IFN-α secretion was detected following CpG or GpC 
ODN stimulation.  These results are consistent with our previous observations with ovine 
JPP cells [1]. Moreover, there was a low level of spontaneous IFN-α secretion by CD21- 
JPP cells. The levels of IFN-α increased significantly compared to the CD21+ JPP cells 
following stimulation with CpG. This result indicates that the CD21- cell population was 
the major source of IFN-α secreting cells in the PP (Fig 15d). Therefore, bovine PP 
CD21+ do not secrete IFN-α , but bovine PP CD21- secrete this cytokine following CpG 
stimulation. 
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5.4.11 Lymphocyte proliferation responses of bovine neonatal PP B cells 
We have previously reported that ovine JPP CD21+ B cells (Bregs) do not proliferate 
[76]. Therefore, we investigated whether bovine CD21+ JPP B cells could also proliferate.  
Unfractionated bovine JPP cells displayed a significant proliferative response when 
stimulated with CpG ODN (Fig 15e).  Similarly, CD21- JPP cells significantly proliferated 
following CpG ODN stimulation. In contrast, bovine CD21+ B cells did not proliferate 
following CpG ODN stimulation (Fig 15e).  These data indicate that bovine CD21+ PP B cells 
do not proliferate in direct response to CpG ODN stimulation. They may require other cells 
such as myeloid cells to respond to CpG stimulation [175].  
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Figure 15. Interleukin (IL)-10 (a), IL-12 (b), IFN
-γ (c) and IFN
-α (d) Secretion and proliferative responses (e) of neonatal bovine JPP cells. 
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5.5 Discussion 
In this paper, we surveyed the frequency of IL-10 producing Bregs cells, in mucosal 
and systemic lymphoid tissues of young sheep. We further investigated whether IL-10 
producing Bregs were unique to sheep or also present in another ruminant species. We 
observed that IL-10 secreting CD21+ B cells were present in both mucosal and systemic 
lymphoid tissues. These investigations provide evidence that IL-10 secreting Bregs are 
distributed in a variety of musocal and systemic tissues, but their frequencies vary. We also 
confirmed that IL-10 secreting Bregs were not unique to sheep but are also present in cattle. 
 
Our first aim was to survey the existence of CD21+ Bregs in the various tissues of sheep. 
Two subpopulations of B cells have been described in sheep. These two B cell sub-
populations have distinct recirculation characteristics and tissue distribution [108]. 
Phenotypically, the two subpopulations are distinguished by their surface expression of 
complement receptors, CD21 (CR2) and CD11b/ CD18 (CR3) [108]. The CD11b+ B cells 
are non-circulating B cells. Unlike these cells, the CD21+ B cells are sIgM low and co-express 
L- selectin.  They populate the splenic and PP follicles, are absent in the splenic marginal 
zones and are the only B cells found in afferent and efferent lymph and all lymph nodes [108]. 
In this experiment we show that the frequency of IL-10 secreting CD21+ B cells varies 
significantly in different lymphoid tissues. These CD21+  B cells are similar to the cells Gupta 
et al, described in sheep since they are also variedly distributed among lymphoid tissues 
[108].  
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The reason for this variation in Breg frequency is presently unknown but should be 
subject of future investigations. One reason may be due to lymphocyte re-circulation that 
ensures Bregs are distributed throughout the body, similar to Tregs recirculation [176]. It may 
also be that some tissues have requirements for a higher frequency of Bregs. For example, 
mucosal tissue may require a high frequency of Bregs due to constant exposure to microbial 
products at these sites. Bregs may be required to control the level of immune activation and 
avoid chronic inflammation. Some IL-10 secreting cells were also present among the CD21- 
population isolated from different tissues. This may be due to contamination of IL-10 
secreting B cells with the CD21- cell fraction as a result of using the MACs for fractionating 
JPP cells into CD21+ and CD21- subpopulations. 
 
In our second investigation of Bregs in neonatal calves, we observed that IL-10 secreting 
CD21+ B cells could be isolated from the JPP of newborn calves. These results are similar to 
our previous observations with ovine JPP [1, 76].   Furthermore, we report that bovine CD21+ 
PP B cells do not secrete IL-12 and IFN-γ, either with or without CpG or GpC ODN 
stimulation. IL-12 is a pro-inflammatory cytokine that influences development of Th-1 type 
responses and is primarily produced by monocytes, macrophages and dendritic cells 
following microbial stimulation. T cells and NK cells up-regulate IFN-γ production, 
proliferate and carry out cytotoxic activity following stimulation with IL-12 [152]. In this 
study, IL-12 was secreted by the bovine CD21- JPP subpopulation but not by CD21+ B cells 
population (Bregs). Similar results were seen when PP cells were assayed for IFN-γ secretion. 
As had been shown before for IL-12, the Bregs did not produce IFN-γ. Therefore, bovine 
CD21+ B cell population do not secrete the pro-inflammatory cytokines, IL-12 and IFN-γ but 
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produce the anti-inflammatory cytokine IL-10. This observation provides evidence that 
CD21+ B cells, with a Breg phenotype also exists in cattle. Also, these purified CD21+ B cells 
did not proliferate in response to CpG ODN stimulation [175]. In contrast, bovine PP CD21- 
cells produced detectable levels of IL-12, IFN-γ and did proliferate after stimulation with 
CpG. Therefore consistent with our results in Chapter 4, bovine PP B cells may also be 
subdivided into a regulatory (CD21+) and an effector (CD21-) B cell population. 
 
In conclusion, we confirmed that IL-10 secreting CD21+ B cells could be isolated from 
both mucosal and systemic lymphoid tissues in the sheep and do exist in PP of neonatal 
calves. 
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6.0 GENERAL DISCUSSION 
The intestinal mucosa is constantly exposed to a diverse array of microbes, some of 
which are pathogenic. Although the real magnitude of the host exposure to pathogens and 
commensal microbes is difficult to assess, it appears that these encounters rarely result in 
inflammation and disease. Mucosal immune defense mechanisms are responsible for host 
protection, however the control of inflammatory responses is important in preserving the 
integrity of the mucosal barriers. 
 
Peyer’s patches are the primary sites for induction of antigen-specific immune 
responses in the intestinal tract. The intestine also expresses PRR, including TLR receptors 
which detects PAMPs from microbes [177]. Understanding how TLR responses are regulated 
in PP will provide valuable information on how innate immune responses are regulated in the 
intestines. MLNs are the key site for induction of tolerance to food proteins, but here they act 
as a firewall to preserve systemic ignorance of commensal organisms, rather than an 
obligatory site for induction of the adaptive response itself [178]. 
 
In this thesis, we started by studying the development of regulatory B cells in sheep PP. 
We clearly show that Bregs develop in utero prior to antigen exposure and are present in young 
sheep. This was achieved by demonstrating the presence of IL-10 secreting CD21+ B in the 
JPP of fetal, neonatal and young lambs.  
 
Like their T cell counterparts (Tregs), Bregs are capable of inhibiting inflammatory 
responses and inducing immune tolerance through the production of IL-10 and TGF [3, 
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142]. IL-10 is an immune regulatory cytokine with pleiotropic functions, including 
suppression of inflammation [143].  IL-10 is produced by different cells including B cells, 
monocytes, macrophage, neutrophils and DCs [122, 127, 131]. We show that in addition to 
the 3-4 month old lambs, neonatal and fetal lamb CD21+ B cells also secrete IL-10 and 
presumably have a regulatory function. This information supports the conclusion that there 
is a competent mucosal immune system present at birth, capable of protecting the newborn 
against unnecessary inflammatory responses induced by enteric flora. The CD21+ B cells 
isolated from fetal PPs would not have been exposed to exogenous antigens and yet they 
produced detectable levels of IL-10 meaning that PP Bregs production of IL-10 is antigen-
independent and Breg development occurs spontaneously. We therefore propose that PP may 
function as a site for the production of natural Bregs analogous to the thymus function as a 
site for natural Treg generation [151]. Presumably the suppressive effects of IL-10 produced 
by PP CD21+ B cells dampens potentially harmful inflammatory responses (e.g. IL-12 and 
IFN-γ) in response to CpG-DNA (and other PAMPs) following exposure to commensal 
microflora at the time of birth. 
 
 In the foetus, this suppressive effect may develop in preparation for colonization of 
the gut lumen with different microbiota which occurs during birth. We consistently 
observed that CD21+ B cells isolated from the jejunal PP of older lambs do not proliferate in 
response to CpG ODN, results that were consistent with earlier observations [1]. However 
CD21+ B cells isolated from the JPPs of fetal and neonatal lambs do proliferate following 
CpG ODN stimulation which may imply that at these early stages of development the B 
cells do not have a defect in the TLR9 signal transduction pathway as reported for older 
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lambs [2]. Alternatively, there may be insufficient Breg activity (due to low numbers of Bregs 
in fetus) to block CpG ODN stimulation. The other possibility may be technical; perhaps a 
subpopulation of fetal and neonatal CD21- B cells capable of proliferating, co-purify with 
CD21+B cells. 
 
We confirmed that regulatory CD72+CD21+ B cells are the only detectable source of 
IL-10 in PP of sheep when using an ELISA. This is important given that in our previous 
studies, we used MACS to enrich the CD21+ B cells population. This procedure could only 
achieve 95% purity, suggesting that the other 5% cell population may contribute to the IL-10 
production within the CD21+ B cells population. Additionally, DCs also express CD21 and 
may contribute to IL-10 production. By using a procedure that negatively sorts B cells, we 
were able to achieve a B cell purity in excess of 99%. Using this highly purified B cell 
population, we have definitively confirmed that B cells are the only source of IL-10 in PP. 
DC and other cell types tested did not contribute to IL-10 production. 
 
In Chapter 3, we provide evidence for the existence of regulatory (CD72+CD21+) and 
effector (CD72+CD21-) B cell subpopulations in the JPP of sheep. To our knowledge, this is 
the first time effector B cells have been described in ovine PP. The effector B cell population 
(CD72+CD21-) in the PP produced IL-12, IFN-γ, and IgM following stimulation with CpG 
ODN. We confirmed that the CD21- population consists primarily of B cells that are 
CD72+CD21-, though it was impossible to completely eliminate the CD72-CD21- population 
due to very low cell numbers. The presence of effector and regulatory B cells in the PP may 
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ensure that effector immune responses generated in the intestine can be appropriately 
regulated.  
 
The frequency of IL-10 secreting Bregs is very low (<0.02%) within the CD21+ 
population. The significance of this remains to be studied. Tregs exists in different 
subpopulations either as natural or inducible Tregs [179]. The sheep Bregs have not been studied 
under disease conditions and therefore it may be that their low numbers increase during 
disease, similar to Tregs. We propose that in disease conditions, some naturally occurring B 
cells may be induced to become Bregs as we have just discovered in an experiment with bovine 
leukaemia virus infected sheep. We observed that inducible B cells that secrete high levels of 
IL-10 were present in blood (data not included in thesis). 
 
In chapter 4, we investigated the presence of IL-10 producing regulatory B cells in a 
second ruminant species. We confirmed that IL-10 secreting Bregs could be isolated from 
cattle and are not unique to sheep. We observed that among bovine CD21+ B cells, there are 
cells that secrete IL10 but fail to secrete IL-12 or IFN-γ following stimulation with CpG or 
GpC ODN. These B cells also do not directly proliferate in response to CpG stimulation. 
These results are consistent with our earlier observations with ovine JPP cells [1, 76]. 
However, bovine B cells may be different from sheep B cells since they require co-
stimulatory signals to proliferate in response to CpG ODN stimulation. 
 
We also surveyed the distribution of IL-10 producing regulatory B cells, in ovine 
mucosal and systemic lymphoid tissues. These investigations provide evidence that IL-10 
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secreting Bregs are present at different frequencies within the CD21+ B cell population isolated 
from different lymphoid tissues. As had been shown in our previous reports, the JPP 
contained the highest frequency of IL-10 secreting Bregs when compared to other mucosal 
tissues evaluated (Mesenteric Lymph nodes, Tonsils and Bronchial lymph nodes) and 
peripheral lymphoid tissues (PBMC, and Spleen). The reason for the high frequency of Bregs  
in the JPP’s is not known but may be due to the fact that these PP are located in direct contact 
with the intestinal lumen and are continuously exposed to microbial molecules. It may be 
necessary to continually dampen inflammatory responses to maintain homeostasis. It is 
interesting to note that there were more IL-10 secreting cells in the mucosal associated 
lymphoid tissues (PP’s, MLN and BLN), compared to the peripheral lymphoid tissues 
(PBMC and spleen). There also seems to be a difference in the secretion of IL-10 by JPP 
CD21- cells by ELISA and ELISpot. This may have resulted from technical issues emanating 
from the fractionation of the PP cells using MACS which may have resulted in some CD21+ 
B cells co-purifying with the CD21- population. ELISpot is also a more sensitive assay than 
ELISA [180]. 
 
 
 
 
 
 
 
 
92 
 
 7.0 CONCLUSION   
In conclusion, we demonstrate that regulatory B cells could be isolated from fetal lambs 
prior to antigen exposure, are present in newborns and 3-4 month old sheep and are widely 
distributed throughout mucosal and systemic lymphoid tissues. Furthermore, functionally 
similar CD21+ Bregs were isolated from the JPP of neonatal calves. Moreover, we 
demonstrated that ovine JPP B cells can be functionally divided into two distinct 
subpopulations; a regulatory and an effector population. Further investigations are required 
to provide detailed information on how these two populations function to regulate immune 
responses in the intestine 
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